data_1b9r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b9r _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.693 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.582 ' CD ' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.65 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.559 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.646 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.62 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG23 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.602 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB2' HG13 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.562 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.659 ' NE1' HD12 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG21 ' CA ' ' A' ' 81' ' ' GLY . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.561 ' CG1' HG12 ' A' ' 88' ' ' VAL . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.561 HG12 ' CG1' ' A' ' 60' ' ' VAL . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.68 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.572 ' HB3' HD13 ' A' ' 97' ' ' LEU . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 94' ' ' MET . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.65 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 7' ' ' ASP . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.629 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.659 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 11' ' ' GLY . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.652 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.63 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 15.2 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.635 ' HA ' HG23 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.457 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 14.5 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.548 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 5' ' ' PHE . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.608 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.695 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.47 ' C ' ' O ' ' A' ' 35' ' ' ILE . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' SER . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.453 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 49' ' ' ARG . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' CG ' ' CG2' ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.612 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.712 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HA3' ' A' ' 81' ' ' GLY . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 56' ' ' TRP . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.56 ' CA ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' N ' ' HE ' ' A' ' 83' ' ' ARG . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.577 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 HD13 ' HG ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' O ' ' CG2' ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.454 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 57' ' ' VAL . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.604 ' CG2' ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.562 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 87' ' ' GLN . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.46 ' HB3' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.487 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' A' ' 84' ' ' LEU . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.56 HG21 ' CA ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.551 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.555 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.712 HD12 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.639 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 99' ' ' VAL . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.43 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.748 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.828 HG21 HG13 ' A' ' 26' ' ' VAL . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.673 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.628 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.498 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' VAL . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.828 HG13 HG21 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.757 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.602 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.757 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.423 HG21 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.533 ' CG2' ' CB ' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' ARG . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.686 ' NE1' HD12 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CA ' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' CG1' ' A' ' 88' ' ' VAL . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.588 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.588 ' CB ' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.588 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 72' ' ' GLN . 2.4 t-20 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' HD11 ' A' ' 71' ' ' LEU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.411 ' HB ' ' OE1' ' A' ' 76' ' ' GLU . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' OE1' ' HB ' ' A' ' 74' ' ' THR . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.525 ' CZ ' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.533 ' CB ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.678 HG23 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.528 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' C ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 102' ' ' PRO . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo . . . . . 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.649 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.662 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 99' ' ' VAL . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 6' ' ' ILE . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 26' ' ' VAL . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.655 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.625 ' HA ' HG23 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 10.2 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.542 ' CD2' HD13 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.531 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.524 ' CG2' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.634 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.539 ' CD1' ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' HG21 ' A' ' 50' ' ' ILE . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CA ' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 93' ' ' SER . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' TRP . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' CG ' ' HE3' ' A' ' 94' ' ' MET . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.579 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 64' ' ' ASN . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.508 ' ND2' ' HE3' ' A' ' 78' ' ' MET . 2.0 t-20 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.508 ' HE3' ' ND2' ' A' ' 68' ' ' ASN . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.533 ' NE ' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' CD1' ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.443 ' CB ' ' NH1' ' A' ' 83' ' ' ARG . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.649 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.527 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.646 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.739 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.518 ' HG2' ' CG1' ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 12.1 Cg_endo . . . . . 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 6' ' ' ILE . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 5' ' ' PHE . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.741 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.681 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.681 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HA ' HG23 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ILE . 12.5 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.735 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.735 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.741 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.454 ' O ' HG22 ' A' ' 44' ' ' VAL . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 43' ' ' CYS . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.417 ' OG1' ' HB1' ' A' ' 37' ' ' ALA . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.644 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 56' ' ' TRP . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' VAL . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.566 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' CZ ' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.478 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 60' ' ' VAL . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' A' ' 90' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CG ' HD12 ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.413 ' HB ' ' CG ' ' A' ' 7' ' ' ASP . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 99' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.659 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.659 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.617 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.708 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 34' ' ' GLY . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 34' ' ' GLY . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.735 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG21 ' CA ' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 56' ' ' TRP . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 71' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.467 ' NE2' ' SD ' ' A' ' 78' ' ' MET . 4.1 mm-40 -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.467 ' SD ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.521 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.531 ' CB ' HD22 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.551 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.735 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.689 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' N ' ' HD3' ' A' ' 102' ' ' PRO . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo . . . . . 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.641 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.639 ' CG1' ' CG1' ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.663 ' O ' HG13 ' A' ' 6' ' ' ILE . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 5' ' ' PHE . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.521 ' N ' HG23 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.643 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.643 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG23 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD23 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.522 ' HE2' ' CA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.522 ' CA ' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.611 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.608 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 38' ' ' GLU . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' ARG . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.573 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.734 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.52 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.676 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.545 HG21 ' CA ' ' A' ' 81' ' ' GLY . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' TRP . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.484 ' CD ' ' CG1' ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.582 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.545 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.462 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 22' ' ' SER . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 88' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.633 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.734 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.489 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.666 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.529 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.653 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.676 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.754 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 26' ' ' VAL . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.666 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 17.1 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.761 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.761 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.754 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 36' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 35' ' ' ILE . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.514 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.573 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.686 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.47 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.562 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG11 ' CE ' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' O ' ' HE1' ' A' ' 94' ' ' MET . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.666 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.551 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.621 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.764 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.654 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo . . . . . 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.523 ' C ' ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.638 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.634 ' O ' HG13 ' A' ' 6' ' ' ILE . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 5' ' ' PHE . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.754 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.654 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.625 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 11.5 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.617 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.627 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.754 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 24' ' ' MET . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' CYS . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.453 ' C ' HG22 ' A' ' 44' ' ' VAL . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' CYS . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 100' ' ' ARG . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.591 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.685 ' NE1' HD12 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.503 HG21 ' HA3' ' A' ' 81' ' ' GLY . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG2' ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.6 ' N ' ' HE ' ' A' ' 83' ' ' ARG . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.628 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.628 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 ' CD2' ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA3' HG21 ' A' ' 57' ' ' VAL . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.513 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' SER . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.466 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 22' ' ' SER . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.692 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.619 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.761 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.643 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.672 HG21 HG11 ' A' ' 26' ' ' VAL . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.607 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 39.1 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.638 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.494 ' CE ' ' CB ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.672 HG11 HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.682 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.632 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.682 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.669 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' CB ' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG3' ' CG2' ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.424 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.478 ' NH1' ' CD2' ' A' ' 71' ' ' LEU . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' HD23 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' A' ' 82' ' ' THR . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.596 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.55 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.703 ' NE1' HD12 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.532 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' TRP . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.452 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.585 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' ASN . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' CD2' ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 71' ' ' LEU . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.551 ' CZ ' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.527 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG22 ' CZ ' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 86' ' ' CYS . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.513 ' CD ' ' OD2' ' A' ' 19' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.666 ' CD1' ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.714 ' N ' ' CD1' ' A' ' 98' ' ' ILE . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.69 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo . . . . . 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.663 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 99' ' ' VAL . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 99' ' ' VAL . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 6' ' ' ILE . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.735 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.654 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 10.4 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG23 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.466 ' SD ' ' CB ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.631 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.759 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.735 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' GLY . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 34' ' ' GLY . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.52 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.422 HG21 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.535 HG22 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' CG ' HG22 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.68 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.694 ' NE1' HD12 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' CA ' ' A' ' 81' ' ' GLY . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 56' ' ' TRP . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.525 ' CB ' ' CD ' ' A' ' 83' ' ' ARG . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.604 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.9 t-20 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.515 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.525 ' CD ' ' CB ' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.466 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.57 ' HA ' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.694 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 37.7 Cg_endo . . . . . 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.639 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 15' ' ' VAL . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 99' ' ' VAL . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.512 ' HA ' HD12 ' A' ' 6' ' ' ILE . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.658 HG13 HG11 ' A' ' 3' ' ' VAL . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.643 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.617 ' HA ' HG23 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.513 ' CB ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.619 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.619 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.483 ' O ' HG11 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 42' ' ' SER . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HB2' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.724 ' NE1' HD12 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.562 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 56' ' ' TRP . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CG ' ' A' ' 87' ' ' GLN . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 71' ' ' LEU . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.538 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.562 ' CG2' ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.63 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.724 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.695 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 7' ' ' ASP . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo . . . . . 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.67 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.644 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 99' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.647 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.641 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 50.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.643 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.601 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.506 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' CG1' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' CB ' HG11 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 ' CB ' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 47' ' ' THR . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HB ' ' CB ' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' CG ' HG22 ' A' ' 82' ' ' THR . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.577 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.826 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.65 ' CD1' ' CD ' ' A' ' 53' ' ' GLU . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 56' ' ' TRP . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.533 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 70' ' ' LEU . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.484 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.537 ' HD2' ' HB2' ' A' ' 63' ' ' ALA . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 87' ' ' GLN . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ARG . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.0 mm-40 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 22' ' ' SER . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.67 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.574 ' HG2' HD13 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.66 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.574 HD13 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.826 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.47 ' HG3' HG13 ' A' ' 6' ' ' ILE . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo . . . . . 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.673 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.532 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.667 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.827 HG21 HG13 ' A' ' 26' ' ' VAL . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.684 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.642 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 1.1 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.619 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.827 HG13 HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.673 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.714 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.549 ' CB ' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' HG11 ' A' ' 44' ' ' VAL . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG22 ' CB ' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.449 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.477 HG13 HD21 ' A' ' 23' ' ' LEU . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.604 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.693 ' NE1' HD12 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.556 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 56' ' ' TRP . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.625 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.625 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 1.8 t-20 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 84' ' ' LEU . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.673 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD3' ' OD2' ' A' ' 19' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.455 ' SD ' ' OD1' ' A' ' 91' ' ' ASP . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.545 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.693 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.484 HG12 ' HD2' ' A' ' 102' ' ' PRO . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' HG12 ' A' ' 101' ' ' VAL . 11.6 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.639 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.534 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.639 ' CG1' ' CG1' ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 99' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.679 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.679 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.466 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.746 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.622 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.746 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.752 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' ' 50' ' ' ILE . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 100' ' ' ARG . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.693 ' NE1' HD12 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 81' ' ' GLY . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' HG12 ' A' ' 88' ' ' VAL . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.592 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.508 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.502 ' ND2' ' SD ' ' A' ' 78' ' ' MET . 0.8 OUTLIER -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.502 ' SD ' ' ND2' ' A' ' 68' ' ' ASN . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.518 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.493 ' NH1' ' HB3' ' A' ' 83' ' ' ARG . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.444 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.648 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.639 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.592 ' HA ' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.693 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 7' ' ' ASP . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.479 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 60.5 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.693 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.582 ' CD ' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.646 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.65 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.559 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.646 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.62 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.637 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG23 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.599 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.602 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' HB2' HG13 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ARG . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.562 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.659 ' NE1' HD12 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG21 ' CA ' ' A' ' 81' ' ' GLY . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.561 ' CG1' HG12 ' A' ' 88' ' ' VAL . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' NE ' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.561 HG12 ' CG1' ' A' ' 60' ' ' VAL . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.68 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.572 ' HB3' HD13 ' A' ' 97' ' ' LEU . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 94' ' ' MET . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.65 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 7' ' ' ASP . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo -73.21 -177.9 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HG ' ' N ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -79.38 178.41 2.33 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.0 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.499 ' N ' ' HG ' ' A' ' 103' ' ' LEU . 51.6 Cg_exo -53.08 92.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.744 2.296 . . . . 0.0 112.012 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.162 -179.795 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.629 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.652 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.659 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 11' ' ' GLY . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.593 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.652 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.63 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 15.2 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.635 ' HA ' HG23 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.487 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 14.5 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.548 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' CE1' ' A' ' 5' ' ' PHE . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.612 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.695 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.608 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.695 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.47 ' C ' ' O ' ' A' ' 35' ' ' ILE . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' HB2' ' S2 ' ' A' ' 106' ' ' FES . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HA ' ' S1 ' ' A' ' 106' ' ' FES . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.453 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 49' ' ' ARG . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' CG ' ' CG2' ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.612 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.712 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.502 HG21 ' HA3' ' A' ' 81' ' ' GLY . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 56' ' ' TRP . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.56 ' CA ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' N ' ' HE ' ' A' ' 83' ' ' ARG . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.577 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.577 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 HD13 ' HG ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' O ' ' CG2' ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.454 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 57' ' ' VAL . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.604 ' CG2' ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.562 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 87' ' ' GLN . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.46 ' HB3' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.487 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' A' ' 84' ' ' LEU . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.56 HG21 ' CA ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.551 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.555 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.712 HD12 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -178.69 4.65 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.9 125.27 82.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HA ' ' NH1' ' A' ' 49' ' ' ARG . 51.0 Cg_exo -54.28 98.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.707 2.271 . . . . 0.0 112.368 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.461 ' S1 ' ' HA ' ' A' ' 43' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.639 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.694 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 99' ' ' VAL . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.43 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.748 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.828 HG21 HG13 ' A' ' 26' ' ' VAL . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.673 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.628 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.498 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.678 ' HA ' HG23 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 26' ' ' VAL . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.828 HG13 HG21 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.757 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.602 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.757 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.423 HG21 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB3' ' S2 ' ' A' ' 106' ' ' FES . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.533 ' CG2' ' CB ' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' ARG . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.686 ' NE1' HD12 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CA ' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.584 ' CG1' ' CG1' ' A' ' 88' ' ' VAL . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.588 ' CB ' ' CB ' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.588 ' CB ' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.588 ' CB ' ' CB ' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 72' ' ' GLN . 2.4 t-20 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 ' N ' HD11 ' A' ' 71' ' ' LEU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' HG3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.411 ' HB ' ' OE1' ' A' ' 76' ' ' GLU . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' OE1' ' HB ' ' A' ' 74' ' ' THR . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' O ' ' OE2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.525 ' CZ ' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.533 ' CB ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.44 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.678 HG23 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.528 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' C ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 102' ' ' PRO . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo -48.38 -166.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.88 146.42 32.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.788 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 105' ' ' ALA . 29.8 Cg_endo -61.99 -170.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.933 2.422 . . . . 0.0 112.482 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.191 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.443 ' S2 ' ' HB3' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.649 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.695 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 99' ' ' VAL . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 6' ' ' ILE . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.823 HG21 HG13 ' A' ' 26' ' ' VAL . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.655 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.625 ' HA ' HG23 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 10.2 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.542 ' CD2' HD13 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.531 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.524 ' CG2' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.634 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' CB ' ' S1 ' ' A' ' 106' ' ' FES . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.539 ' CD1' ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' HG21 ' A' ' 50' ' ' ILE . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.739 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.668 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG21 ' CA ' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 93' ' ' SER . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' TRP . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' CG ' ' HE3' ' A' ' 94' ' ' MET . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.579 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 64' ' ' ASN . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.508 ' ND2' ' HE3' ' A' ' 78' ' ' MET . 2.0 t-20 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.508 ' HE3' ' ND2' ' A' ' 68' ' ' ASN . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.533 ' NE ' HG23 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.539 ' CB ' ' CD1' ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.443 ' CB ' ' NH1' ' A' ' 83' ' ' ARG . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.649 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.527 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.646 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.739 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.612 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.518 ' HG2' ' CG1' ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 12.1 Cg_endo -54.74 -170.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.3 mp -111.64 162.52 20.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 168.38 22.84 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.998 2.465 . . . . 0.0 112.087 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.315 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.52 ' S1 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.701 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.639 ' O ' HG13 ' A' ' 6' ' ' ILE . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 5' ' ' PHE . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.467 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.741 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.681 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.681 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.592 ' HA ' HG23 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ILE . 12.5 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.735 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.735 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.741 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.454 ' O ' HG22 ' A' ' 44' ' ' VAL . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 43' ' ' CYS . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.429 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.417 ' OG1' ' HB1' ' A' ' 37' ' ' ALA . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.644 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 56' ' ' TRP . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' VAL . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' CZ ' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.478 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 60' ' ' VAL . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.568 HD13 ' CD1' ' A' ' 90' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CG ' HD12 ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' HB ' ' CG ' ' A' ' 7' ' ' ASP . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 72.7 Cg_endo -76.43 -179.53 5.39 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.0 132.52 29.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.719 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.44 -179.69 4.0 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.901 2.401 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.988 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.429 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.655 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 99' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.659 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.659 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.518 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.617 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.708 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 34' ' ' GLY . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 34' ' ' GLY . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HA ' ' S2 ' ' A' ' 106' ' ' FES . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.468 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 102' ' ' PRO . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.735 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG21 ' CA ' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 56' ' ' TRP . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.6 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HG2' ' CB ' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 71' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.467 ' NE2' ' SD ' ' A' ' 78' ' ' MET . 4.1 mm-40 -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.467 ' SD ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' ' OG1' ' A' ' 82' ' ' THR . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.521 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.531 ' CB ' HD22 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.551 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.735 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.689 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' N ' ' HD3' ' A' ' 102' ' ' PRO . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo -86.95 179.5 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 HD22 ' HD2' ' A' ' 104' ' ' PRO . 29.3 mt -151.48 164.37 20.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.335 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.491 ' HD2' HD22 ' A' ' 103' ' ' LEU . 60.9 Cg_endo -74.04 95.53 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.579 2.186 . . . . 0.0 112.321 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.168 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.641 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.639 ' CG1' ' CG1' ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.663 ' O ' HG13 ' A' ' 6' ' ' ILE . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 5' ' ' PHE . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.521 ' N ' HG23 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.643 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.643 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG23 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.419 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD23 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.522 ' HE2' ' CA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.522 ' CA ' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.611 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.608 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 38' ' ' GLU . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' ARG . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' N ' HG22 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.734 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.52 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.676 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.545 HG21 ' CA ' ' A' ' 81' ' ' GLY . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 56' ' ' TRP . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.484 ' CD ' ' CG1' ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.582 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.545 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.462 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 22' ' ' SER . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.545 ' CE ' HG13 ' A' ' 88' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.633 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.734 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.54 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.489 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo -70.27 -177.29 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 151.21 82.35 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 100.38 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.775 2.317 . . . . 0.0 112.45 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.244 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.442 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.666 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.529 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.653 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.676 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.754 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.833 HG21 HG13 ' A' ' 26' ' ' VAL . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.666 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.533 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 17.1 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.833 HG13 HG21 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.761 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.761 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.754 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' ' CB ' ' A' ' 36' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 35' ' ' ILE . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.514 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.573 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.764 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.686 ' NE1' HD12 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 83' ' ' ARG . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.454 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.47 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.562 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG11 ' CE ' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' O ' ' HE1' ' A' ' 94' ' ' MET . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.666 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.551 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.621 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.764 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.654 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo -48.97 -164.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 141.5 35.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.197 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -32.47 113.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.438 2.759 . . . . 0.0 112.795 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.11 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.523 ' C ' ' HA2' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.638 HG11 HG13 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.634 ' O ' HG13 ' A' ' 6' ' ' ILE . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 5' ' ' PHE . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.535 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.754 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.654 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.625 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 11.5 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.617 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.627 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.754 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 24' ' ' MET . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' CB ' ' S2 ' ' A' ' 106' ' ' FES . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 39' ' ' CYS . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.453 ' C ' HG22 ' A' ' 44' ' ' VAL . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' CYS . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 100' ' ' ARG . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.591 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.685 ' NE1' HD12 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.503 HG21 ' HA3' ' A' ' 81' ' ' GLY . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' CG2' ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.6 ' N ' ' HE ' ' A' ' 83' ' ' ARG . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.628 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.628 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 ' CD2' ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA3' HG21 ' A' ' 57' ' ' VAL . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.513 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.494 ' O ' ' CB ' ' A' ' 22' ' ' SER . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.466 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 22' ' ' SER . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.692 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.619 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.761 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo -75.08 -178.99 4.57 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -178.74 156.17 0.91 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.99 66.06 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.816 2.344 . . . . 0.0 112.213 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.987 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.509 ' S2 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.643 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.657 HG11 HG13 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.669 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.672 HG21 HG11 ' A' ' 26' ' ' VAL . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.607 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 39.1 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.638 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.494 ' CE ' ' CB ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.672 HG11 HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.682 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.632 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.682 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.669 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' CB ' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HG3' ' CG2' ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.424 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.478 ' NH1' ' CD2' ' A' ' 71' ' ' LEU . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' HD23 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HG3' HG22 ' A' ' 82' ' ' THR . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.596 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.55 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.703 ' NE1' HD12 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.532 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' TRP . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.452 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.585 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' ASN . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' CD2' ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 71' ' ' LEU . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.551 ' CZ ' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.527 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG22 ' CZ ' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 86' ' ' CYS . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.513 ' CD ' ' OD2' ' A' ' 19' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.666 ' CD1' ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.714 ' N ' ' CD1' ' A' ' 98' ' ' ILE . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.69 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo -65.92 -162.02 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.7 165.42 53.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.986 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.53 -177.84 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.819 2.346 . . . . 0.0 112.236 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.053 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.459 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.663 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 99' ' ' VAL . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 99' ' ' VAL . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 6' ' ' ILE . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.735 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.654 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 10.4 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG23 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD2' ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.466 ' SD ' ' CB ' ' A' ' 86' ' ' CYS . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.631 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.759 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.735 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' GLY . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 34' ' ' GLY . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.52 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.422 HG21 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.535 HG22 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' CG ' HG22 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.68 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.694 ' NE1' HD12 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG21 ' CA ' ' A' ' 81' ' ' GLY . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 56' ' ' TRP . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.525 ' CB ' ' CD ' ' A' ' 83' ' ' ARG . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.604 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' O ' ' ND2' ' A' ' 68' ' ' ASN . 1.9 t-20 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.519 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.515 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.525 ' CD ' ' CB ' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.466 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.656 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.663 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.57 ' HA ' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.694 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 37.7 Cg_endo -65.43 -175.19 0.4 Allowed 'Trans proline' 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 82.7 mt -84.97 131.28 49.36 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.106 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 24.7 Cg_exo -62.57 -177.64 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.63 2.22 . . . . 0.0 112.121 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.027 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.639 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 15' ' ' VAL . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 99' ' ' VAL . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' HA ' HD12 ' A' ' 6' ' ' ILE . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.658 HG13 HG11 ' A' ' 3' ' ' VAL . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.643 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.642 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.502 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.617 ' HA ' HG23 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.513 ' CB ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.619 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.73 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.619 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.73 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.483 ' O ' HG11 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 42' ' ' SER . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HB2' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.724 ' NE1' HD12 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.562 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 56' ' ' TRP . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' HB2' ' CG2' ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.59 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HG3' ' CG ' ' A' ' 87' ' ' GLN . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 71' ' ' LEU . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.538 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.562 ' CG2' ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.546 ' HG2' ' CG2' ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.63 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.724 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.695 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 7' ' ' ASP . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo -43.7 -173.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.505 ' CD2' ' C ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -158.81 160.1 29.33 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.883 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 103' ' ' LEU . 1.0 OUTLIER -43.85 88.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.222 2.615 . . . . 0.0 112.225 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' LEU . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.175 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.455 ' S2 ' ' O ' ' A' ' 36' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.67 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.647 HG11 HG13 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.644 ' CD1' ' CG2' ' A' ' 99' ' ' VAL . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 99' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.555 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.647 HG13 HG11 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.641 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 50.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.643 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.601 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.71 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.506 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' CG1' ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' CB ' HG11 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 ' CB ' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 47' ' ' THR . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.477 ' HB ' ' CB ' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' CG ' HG22 ' A' ' 82' ' ' THR . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.577 ' CG2' ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.826 ' HG3' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.65 ' CD1' ' CD ' ' A' ' 53' ' ' GLU . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 56' ' ' TRP . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.533 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD13 ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HG ' HD13 ' A' ' 70' ' ' LEU . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' HG12 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.484 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.537 ' HD2' ' HB2' ' A' ' 63' ' ' ALA . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 87' ' ' GLN . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ARG . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.0 mm-40 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 22' ' ' SER . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.67 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.574 ' HG2' HD13 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.66 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.574 HD13 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.826 ' HB ' ' HG3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.47 ' HG3' HG13 ' A' ' 6' ' ' ILE . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo -85.13 48.44 2.29 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.465 ' HG ' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -83.77 175.72 4.45 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.448 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' HD2' ' HG ' ' A' ' 103' ' ' LEU . 97.1 Cg_endo -91.87 154.06 3.36 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.893 2.396 . . . . 0.0 112.267 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' FES . . . . . 0.459 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.673 ' HG2' ' CG2' ' A' ' 90' ' ' ILE . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.532 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.667 HG11 HG13 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.702 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 99' ' ' VAL . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.746 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.827 HG21 HG13 ' A' ' 26' ' ' VAL . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.684 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.642 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 1.1 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.619 ' CD1' ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.827 HG13 HG21 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.673 ' HB2' ' CG2' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.714 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.549 ' CB ' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' O ' HG11 ' A' ' 44' ' ' VAL . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG22 ' CB ' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.449 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.477 HG13 HD21 ' A' ' 23' ' ' LEU . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.604 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.693 ' NE1' HD12 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 56' ' ' TRP . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' CZ ' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.625 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.625 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 1.8 t-20 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 84' ' ' LEU . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.565 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.673 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD3' ' OD2' ' A' ' 19' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.455 ' SD ' ' OD1' ' A' ' 91' ' ' ASP . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.545 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.693 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.484 HG12 ' HD2' ' A' ' 102' ' ' PRO . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' HG12 ' A' ' 101' ' ' VAL . 11.6 Cg_endo -55.16 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.96 127.82 29.09 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -91.58 118.28 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.395 2.73 . . . . 0.0 112.315 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.132 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.639 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.534 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.639 ' CG1' ' CG1' ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.627 ' CZ ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 99' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.679 ' CG2' ' H ' ' A' ' 16' ' ' ASP . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.679 ' H ' ' CG2' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.466 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.627 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.746 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.602 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.622 ' OD1' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.746 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.752 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.499 ' O ' ' N ' ' A' ' 50' ' ' ILE . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 100' ' ' ARG . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.693 ' NE1' HD12 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 81' ' ' GLY . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' HG12 ' A' ' 88' ' ' VAL . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.592 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.592 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.508 ' CG ' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.502 ' ND2' ' SD ' ' A' ' 78' ' ' MET . 0.8 OUTLIER -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.516 ' CD1' ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.502 ' SD ' ' ND2' ' A' ' 68' ' ' ASN . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.518 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.493 ' NH1' ' HB3' ' A' ' 83' ' ' ARG . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.444 HD13 ' OE1' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.648 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.461 ' SD ' HG12 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.639 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.592 ' HA ' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.693 HD12 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 7' ' ' ASP . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.479 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 60.5 Cg_endo -72.11 -178.06 3.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 104' ' ' PRO . 1.6 mt -149.28 175.22 2.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.705 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 103' ' ' LEU . 98.2 Cg_endo -85.97 99.63 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.792 2.328 . . . . 0.0 112.613 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.022 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.887 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.908 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.446 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG22 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 57.5 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.059 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.745 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.786 ' N ' HG22 ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' OE1' HG23 ' A' ' 36' ' ' VAL . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.787 ' HB2' HG12 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 50' ' ' ILE . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HD23 ' A' ' 23' ' ' LEU . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.647 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.139 ' NE1' HD13 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 62' ' ' GLU . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.755 HG22 ' HG2' ' A' ' 94' ' ' MET . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 56' ' ' TRP . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 66' ' ' ASP . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.75 ' CD2' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 84' ' ' LEU . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.644 HG22 ' NH1' ' A' ' 83' ' ' ARG . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.676 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.685 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG2' HG22 ' A' ' 59' ' ' ILE . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.965 ' C ' HD12 ' A' ' 98' ' ' ILE . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.139 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 6' ' ' ILE . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.043 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.919 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.898 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.631 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 55.0 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' HG22 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.631 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 57.0 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.884 HD11 HD21 ' A' ' 97' ' ' LEU . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.743 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.577 HG23 ' CE ' ' A' ' 24' ' ' MET . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' SER . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.822 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 48' ' ' CYS . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 1.051 ' CG ' HG23 ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.892 HD12 HG21 ' A' ' 60' ' ' VAL . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.136 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HG2' ' A' ' 94' ' ' MET . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.896 ' CB ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.799 ' HB1' ' HG3' ' A' ' 67' ' ' GLU . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.799 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' O ' HG23 ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 82' ' ' THR . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.051 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 67' ' ' GLU . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' CB ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.909 ' HG2' HG22 ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.719 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.136 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.023 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' VAL . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 5' ' ' PHE . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.579 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.058 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.951 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.683 ' HA ' HG22 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' SER . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.774 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.058 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.901 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.901 ' HD2' HG12 ' A' ' 32' ' ' VAL . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.819 HG22 ' CG2' ' A' ' 36' ' ' VAL . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.819 ' CG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.66 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.639 HG21 ' HB3' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.56 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 60' ' ' VAL . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.605 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.108 ' NE1' HD13 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG13 ' HA2' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD22 ' OE2' ' A' ' 67' ' ' GLU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.766 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.56 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.606 ' CD ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' N ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.461 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.788 HG11 HG11 ' A' ' 60' ' ' VAL . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.88 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.108 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.578 HG21 ' OD2' ' A' ' 7' ' ' ASP . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo . . . . . 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.75 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.813 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 5' ' ' PHE . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.14 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.938 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.629 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG22 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 45.0 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.54 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.728 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.763 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 26' ' ' VAL . 5.5 mm-40 -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.14 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.744 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 44' ' ' VAL . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.864 HD12 ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 82' ' ' THR . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.034 HG22 ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.034 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.138 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB2' HG22 ' A' ' 88' ' ' VAL . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.765 ' HB2' ' CD ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.606 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.657 ' OE1' HD11 ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.765 ' CD ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.657 HD11 ' OE1' ' A' ' 67' ' ' GLU . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.864 ' CB ' HD12 ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.921 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.75 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.138 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HG2' HG13 ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_endo . . . . . 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.786 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.687 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.025 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.761 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.127 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.623 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.623 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 51.9 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 99' ' ' VAL . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.812 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.127 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.985 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.985 ' HD2' HG12 ' A' ' 32' ' ' VAL . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.694 ' H ' HG23 ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 42' ' ' SER . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 60' ' ' VAL . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.154 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.901 HG22 ' SD ' ' A' ' 94' ' ' MET . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.563 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 74' ' ' THR . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 22' ' ' SER . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.746 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 1.044 ' CB ' HD21 ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.786 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.046 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.154 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 6' ' ' ILE . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.001 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.897 ' CE2' HD12 ' A' ' 23' ' ' LEU . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.126 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.925 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.514 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.61 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.432 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.052 HD23 ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.126 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.751 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 36' ' ' VAL . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 35' ' ' ILE . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.715 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.678 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 ' SG ' ' A' ' 45' ' ' CYS . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.456 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.729 ' CG2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.742 ' HG3' HG23 ' A' ' 82' ' ' THR . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.016 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.016 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.118 ' NE1' HD13 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.676 HG13 ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.86 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 70' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 71' ' ' LEU . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.742 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 1.052 ' CB ' HD23 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' HB3' ' C ' ' A' ' 20' ' ' GLY . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.884 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.118 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.026 HG11 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 6' ' ' ILE . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo . . . . . 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.743 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.006 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.108 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 90' ' ' ILE . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.656 ' HE3' ' O ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HG2' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.108 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 39' ' ' CYS . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 36' ' ' VAL . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.065 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.065 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.127 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 62' ' ' GLU . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 93' ' ' SER . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 88' ' ' VAL . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 60' ' ' VAL . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 60' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.127 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.884 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ILE . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.714 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.113 HG22 HD13 ' A' ' 97' ' ' LEU . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 99' ' ' VAL . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.766 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.089 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.614 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 67.5 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.677 ' N ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.718 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.089 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.766 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.807 HG13 HG11 ' A' ' 101' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 48' ' ' CYS . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.705 ' HB3' HG21 ' A' ' 36' ' ' VAL . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.032 HG22 ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.032 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.094 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 53' ' ' GLU . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.027 HG22 ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.7 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.7 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.693 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' NE ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.857 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.494 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.927 HG13 ' HE1' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.712 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 1.027 ' HG2' HG22 ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.714 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.113 HD13 HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.094 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.807 HG11 HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo . . . . . 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.997 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.59 ' N ' HG22 ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.591 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.77 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.132 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.929 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.617 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 49.2 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.784 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.132 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.886 HG12 ' HD2' ' A' ' 33' ' ' PRO . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.886 ' HD2' HG12 ' A' ' 32' ' ' VAL . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 50' ' ' ILE . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.793 HG12 ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 35' ' ' ILE . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' CG ' HG23 ' A' ' 82' ' ' THR . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 60' ' ' VAL . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.803 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.121 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 53' ' ' GLU . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.76 ' CG ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.635 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.892 ' HA ' HD23 ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HE1' ' A' ' 78' ' ' MET . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' LEU . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HE1' HD21 ' A' ' 68' ' ' ASN . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.432 ' C ' ' HG1' ' A' ' 82' ' ' THR . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HD2' ' HB3' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 50' ' ' ILE . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 84' ' ' LEU . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.76 HG21 ' CG ' ' A' ' 62' ' ' GLU . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.841 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.793 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.888 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.121 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.919 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.045 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.918 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.723 ' OD1' HG21 ' A' ' 101' ' ' VAL . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.92 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.693 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 22.6 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.436 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.054 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.755 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.704 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.835 ' HG3' HG21 ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.835 HG21 ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.655 ' O ' HD13 ' A' ' 50' ' ' ILE . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.676 HG21 HD21 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.641 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.53 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.98 HG22 ' HG2' ' A' ' 94' ' ' MET . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.643 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.586 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' LEU . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 66' ' ' ASP . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.448 HG23 ' OE2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' NH1' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.585 ' N ' HG12 ' A' ' 88' ' ' VAL . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.529 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.98 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo . . . . . 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG12 ' CG1' ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.84 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 5' ' ' PHE . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 6' ' ' ILE . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.118 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.496 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 13.1 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.496 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.84 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.118 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.969 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.969 ' HD2' HG12 ' A' ' 32' ' ' VAL . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.637 HG22 HG12 ' A' ' 36' ' ' VAL . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 35' ' ' ILE . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.604 HG21 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.806 ' CG ' HG23 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.657 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.112 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.773 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.618 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.773 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 11.5 t30 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 70' ' ' LEU . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.722 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.604 ' CB ' HG21 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.997 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.765 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.927 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.112 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' ILE . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 101' ' ' VAL . 37.7 Cg_endo . . . . . 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.046 HG22 HD13 ' A' ' 97' ' ' LEU . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' ILE . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.807 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.821 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.119 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.886 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.748 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.807 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.119 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.738 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 35' ' ' ILE . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.928 ' HB2' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.928 HG22 ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HB3' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 71' ' ' LEU . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.86 HD12 ' CB ' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.642 HD12 HG21 ' A' ' 60' ' ' VAL . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.621 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.123 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' SER . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.975 HG22 ' HG2' ' A' ' 94' ' ' MET . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.642 HD22 ' O ' ' A' ' 70' ' ' LEU . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.86 ' CB ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.56 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.659 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.671 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.975 ' HG2' HG22 ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.712 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.123 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 6' ' ' ILE . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo . . . . . 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.949 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.743 ' OD2' HG21 ' A' ' 101' ' ' VAL . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.932 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 9.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.627 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.81 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.064 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.604 ' HB2' HG12 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.85 ' HA ' HG12 ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' NH1' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB3' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 50' ' ' ILE . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.045 HG22 ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.045 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.655 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.129 ' NE1' HD13 ' A' ' 98' ' ' ILE . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.866 HG13 ' HE1' ' A' ' 94' ' ' MET . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.564 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.913 ' HA ' HD23 ' A' ' 70' ' ' LEU . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' NH1' ' A' ' 49' ' ' ARG . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 57' ' ' VAL . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.736 ' NH2' HG21 ' A' ' 88' ' ' VAL . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.568 ' HB3' HD12 ' A' ' 50' ' ' ILE . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 60' ' ' VAL . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.698 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.938 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.938 HD11 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.129 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.685 ' H ' HG12 ' A' ' 99' ' ' VAL . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo . . . . . 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.886 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.074 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.963 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.696 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 7.2 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.074 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.878 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.878 ' HD2' HG12 ' A' ' 32' ' ' VAL . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 36' ' ' VAL . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 49' ' ' ARG . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.659 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.745 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.632 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.662 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 18.5 t30 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 74' ' ' THR . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 HD13 ' A' ' 71' ' ' LEU . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.416 ' HG1' ' CD ' ' A' ' 51' ' ' GLU . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.581 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.699 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.641 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.7 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.873 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 6' ' ' ILE . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.811 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.769 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.123 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.961 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.669 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.076 HD11 HD21 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.489 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.672 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.123 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.904 ' HD2' HG12 ' A' ' 32' ' ' VAL . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB1' HD11 ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.915 ' HA ' HG12 ' A' ' 36' ' ' VAL . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 36' ' ' VAL . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.627 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 60' ' ' VAL . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.111 ' NE1' HD13 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 56' ' ' TRP . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.668 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t30 -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.91 HD11 ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.5 mm-40 -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.539 ' HG2' HD12 ' A' ' 84' ' ' LEU . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.733 ' HG2' HG22 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.111 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.743 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.654 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 6' ' ' ILE . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.479 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 60.5 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.887 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.908 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.446 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG22 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 57.5 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.059 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.745 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.786 ' N ' HG22 ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' OE1' HG23 ' A' ' 36' ' ' VAL . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.787 ' HB2' HG12 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 50' ' ' ILE . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HD23 ' A' ' 23' ' ' LEU . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.647 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.139 ' NE1' HD13 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 62' ' ' GLU . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.755 HG22 ' HG2' ' A' ' 94' ' ' MET . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 56' ' ' TRP . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 66' ' ' ASP . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.75 ' CD2' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 84' ' ' LEU . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG22 ' NH1' ' A' ' 83' ' ' ARG . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.676 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.685 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG2' HG22 ' A' ' 59' ' ' ILE . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.965 ' C ' HD12 ' A' ' 98' ' ' ILE . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.139 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 6' ' ' ILE . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo -73.21 -177.9 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -79.38 178.41 2.33 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.0 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' N ' ' HG ' ' A' ' 103' ' ' LEU . 51.6 Cg_exo -53.08 92.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.744 2.296 . . . . 0.0 112.012 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.162 -179.795 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.043 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.919 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.898 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.631 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 55.0 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' HG22 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.631 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 57.0 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.884 HD11 HD21 ' A' ' 97' ' ' LEU . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.743 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.577 HG23 ' CE ' ' A' ' 24' ' ' MET . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' HB3' ' S2 ' ' A' ' 106' ' ' FES . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HA ' ' S1 ' ' A' ' 106' ' ' FES . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.822 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 48' ' ' CYS . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.051 ' CG ' HG23 ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.892 HD12 HG21 ' A' ' 60' ' ' VAL . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.136 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HG2' ' A' ' 94' ' ' MET . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.896 ' CB ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.799 ' HB1' ' HG3' ' A' ' 67' ' ' GLU . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.799 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' O ' HG23 ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 82' ' ' THR . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.051 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 67' ' ' GLU . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' CB ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.909 ' HG2' HG22 ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.719 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.136 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -178.69 4.65 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.539 ' N ' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -79.9 125.27 82.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 51.0 Cg_exo -54.28 98.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.707 2.271 . . . . 0.0 112.368 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.709 ' S2 ' ' HB3' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.023 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' VAL . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 5' ' ' PHE . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.579 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.058 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.951 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.683 ' HA ' HG22 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' SER . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.774 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.058 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.901 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.901 ' HD2' HG12 ' A' ' 32' ' ' VAL . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.819 HG22 ' CG2' ' A' ' 36' ' ' VAL . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.819 ' CG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.66 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB3' ' S2 ' ' A' ' 106' ' ' FES . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.639 HG21 ' HB3' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.56 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 60' ' ' VAL . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.605 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.108 ' NE1' HD13 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG13 ' HA2' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD22 ' OE2' ' A' ' 67' ' ' GLU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.766 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.56 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.606 ' CD ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 ' S1 ' ' A' ' 106' ' ' FES . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.461 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.788 HG11 HG11 ' A' ' 60' ' ' VAL . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.88 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.108 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.578 HG21 ' OD2' ' A' ' 7' ' ' ASP . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo -48.38 -166.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.88 146.42 32.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.788 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 105' ' ' ALA . 29.8 Cg_endo -61.99 -170.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.933 2.422 . . . . 0.0 112.482 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.191 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.438 ' S1 ' HD13 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.75 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 5' ' ' PHE . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.14 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.938 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.629 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG22 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 45.0 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.54 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.728 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.763 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 26' ' ' VAL . 5.5 mm-40 -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.14 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.744 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' CB ' ' S1 ' ' A' ' 106' ' ' FES . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 44' ' ' VAL . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.864 HD12 ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 82' ' ' THR . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.034 HG22 ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.034 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.138 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB2' HG22 ' A' ' 88' ' ' VAL . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.765 ' HB2' ' CD ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.606 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.657 ' OE1' HD11 ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.765 ' CD ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.657 HD11 ' OE1' ' A' ' 67' ' ' GLU . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.864 ' CB ' HD12 ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.921 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.75 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.138 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.617 HG21 ' CE1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HG2' HG13 ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_endo -54.74 -170.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.3 mp -111.64 162.52 20.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 168.38 22.84 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.998 2.465 . . . . 0.0 112.087 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.315 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.52 ' S1 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.786 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.687 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.025 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.761 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.127 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.623 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.623 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 51.9 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 99' ' ' VAL . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.812 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.127 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.985 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.985 ' HD2' HG12 ' A' ' 32' ' ' VAL . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.694 ' H ' HG23 ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 42' ' ' SER . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 60' ' ' VAL . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.154 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.901 HG22 ' SD ' ' A' ' 94' ' ' MET . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.563 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 74' ' ' THR . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 22' ' ' SER . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.746 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 1.044 ' CB ' HD21 ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.786 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.046 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.154 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 6' ' ' ILE . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.43 -179.53 5.39 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.552 ' N ' HD23 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -94.0 132.52 29.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.719 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.44 -179.69 4.0 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.901 2.401 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.988 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.429 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.001 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.897 ' CE2' HD12 ' A' ' 23' ' ' LEU . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.126 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.925 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.514 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.61 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.432 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.052 HD23 ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.126 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.751 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 36' ' ' VAL . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 35' ' ' ILE . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.715 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.678 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 ' SG ' ' A' ' 45' ' ' CYS . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.456 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.729 ' CG2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.742 ' HG3' HG23 ' A' ' 82' ' ' THR . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.016 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.016 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.118 ' NE1' HD13 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.676 HG13 ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.86 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 70' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 71' ' ' LEU . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.742 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 1.052 ' CB ' HD23 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' HB3' ' C ' ' A' ' 20' ' ' GLY . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.884 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.118 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.026 HG11 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 6' ' ' ILE . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo -86.95 179.5 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 104' ' ' PRO . 29.3 mt -151.48 164.37 20.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.335 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 103' ' ' LEU . 60.9 Cg_endo -74.04 95.53 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.579 2.186 . . . . 0.0 112.321 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.168 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.743 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.006 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.108 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 90' ' ' ILE . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.656 ' HE3' ' O ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HG2' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.108 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 39' ' ' CYS . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 36' ' ' VAL . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.065 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.065 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.127 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 62' ' ' GLU . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 93' ' ' SER . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 88' ' ' VAL . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 60' ' ' VAL . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 60' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.127 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.884 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ILE . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo -70.27 -177.29 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -76.74 151.21 82.35 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.548 ' HD2' HD23 ' A' ' 103' ' ' LEU . 74.5 Cg_endo -75.3 100.38 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.775 2.317 . . . . 0.0 112.45 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.244 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.442 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.714 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.113 HG22 HD13 ' A' ' 97' ' ' LEU . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 99' ' ' VAL . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.766 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.089 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.614 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 67.5 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.677 ' N ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.718 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.089 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.766 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.807 HG13 HG11 ' A' ' 101' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 48' ' ' CYS . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.705 ' HB3' HG21 ' A' ' 36' ' ' VAL . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.032 HG22 ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.032 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.094 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 53' ' ' GLU . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.027 HG22 ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.7 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.7 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.693 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' NE ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.857 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.494 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.927 HG13 ' HE1' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.712 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 1.027 ' HG2' HG22 ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.714 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.113 HD13 HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.094 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.807 HG11 HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo -48.97 -164.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 141.5 35.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.197 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -32.47 113.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.438 2.759 . . . . 0.0 112.795 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.11 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.997 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.59 ' N ' HG22 ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.591 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.77 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.132 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.929 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.617 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 18' ' ' GLN . 49.2 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.784 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.132 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.886 HG12 ' HD2' ' A' ' 33' ' ' PRO . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.886 ' HD2' HG12 ' A' ' 32' ' ' VAL . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 50' ' ' ILE . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.793 HG12 ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 35' ' ' ILE . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' CG ' HG23 ' A' ' 82' ' ' THR . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 60' ' ' VAL . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.803 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.121 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 53' ' ' GLU . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.76 ' CG ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.635 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.892 ' HA ' HD23 ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HE1' ' A' ' 78' ' ' MET . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' LEU . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HE1' HD21 ' A' ' 68' ' ' ASN . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.432 ' C ' ' HG1' ' A' ' 82' ' ' THR . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HD2' ' HB3' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 50' ' ' ILE . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 84' ' ' LEU . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.76 HG21 ' CG ' ' A' ' 62' ' ' GLU . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.841 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.793 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.888 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.121 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.919 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo -75.08 -178.99 4.57 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -178.74 156.17 0.91 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 103' ' ' LEU . 16.9 Cg_exo -66.99 66.06 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.816 2.344 . . . . 0.0 112.213 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.987 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.509 ' S2 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.045 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.918 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.723 ' OD1' HG21 ' A' ' 101' ' ' VAL . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.92 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.693 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 22.6 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.436 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.054 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.755 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.704 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.835 ' HG3' HG21 ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.835 HG21 ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.655 ' O ' HD13 ' A' ' 50' ' ' ILE . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.676 HG21 HD21 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.641 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.98 HG22 ' HG2' ' A' ' 94' ' ' MET . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.643 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.586 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' LEU . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 66' ' ' ASP . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.448 HG23 ' OE2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' NH1' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.585 ' N ' HG12 ' A' ' 88' ' ' VAL . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.529 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.98 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo -65.92 -162.02 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.7 165.42 53.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.986 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . 26.4 Cg_exo -62.53 -177.84 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.819 2.346 . . . . 0.0 112.236 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.053 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.459 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG12 ' CG1' ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.84 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 5' ' ' PHE . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 6' ' ' ILE . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.118 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.496 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 13.1 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.496 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.84 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.118 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.969 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.969 ' HD2' HG12 ' A' ' 32' ' ' VAL . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.637 HG22 HG12 ' A' ' 36' ' ' VAL . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 35' ' ' ILE . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.604 HG21 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.806 ' CG ' HG23 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.657 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.112 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.773 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.618 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.773 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 11.5 t30 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 70' ' ' LEU . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.604 ' CB ' HG21 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.997 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.765 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.927 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.112 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' ILE . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 101' ' ' VAL . 37.7 Cg_endo -65.43 -175.19 0.4 Allowed 'Trans proline' 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 82.7 mt -84.97 131.28 49.36 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.106 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 24.7 Cg_exo -62.57 -177.64 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.63 2.22 . . . . 0.0 112.121 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.027 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.046 HG22 HD13 ' A' ' 97' ' ' LEU . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' ILE . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.807 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.821 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.119 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.886 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.748 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.807 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.119 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.738 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 35' ' ' ILE . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.928 ' HB2' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.928 HG22 ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HB3' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 71' ' ' LEU . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.86 HD12 ' CB ' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.642 HD12 HG21 ' A' ' 60' ' ' VAL . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.123 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' SER . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.975 HG22 ' HG2' ' A' ' 94' ' ' MET . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.642 HD22 ' O ' ' A' ' 70' ' ' LEU . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.86 ' CB ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.56 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.659 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.671 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.975 ' HG2' HG22 ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.712 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.123 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 6' ' ' ILE . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo -43.7 -173.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -158.81 160.1 29.33 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.883 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.725 ' N ' HD22 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -43.85 88.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.222 2.615 . . . . 0.0 112.225 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' LEU . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.175 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.455 ' S2 ' ' O ' ' A' ' 36' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.949 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.743 ' OD2' HG21 ' A' ' 101' ' ' VAL . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.932 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 9.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.627 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.451 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.81 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.064 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.604 ' HB2' HG12 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.85 ' HA ' HG12 ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' NH1' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB3' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 50' ' ' ILE . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.045 HG22 ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.045 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.655 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.129 ' NE1' HD13 ' A' ' 98' ' ' ILE . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.866 HG13 ' HE1' ' A' ' 94' ' ' MET . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.564 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.913 ' HA ' HD23 ' A' ' 70' ' ' LEU . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' NH1' ' A' ' 49' ' ' ARG . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 57' ' ' VAL . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.736 ' NH2' HG21 ' A' ' 88' ' ' VAL . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD23 ' S1 ' ' A' ' 106' ' ' FES . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.568 ' HB3' HD12 ' A' ' 50' ' ' ILE . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 60' ' ' VAL . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.698 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.938 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.938 HD11 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.129 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.685 ' H ' HG12 ' A' ' 99' ' ' VAL . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo -85.13 48.44 2.29 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -83.77 175.72 4.45 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.448 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.464 ' HD2' ' HG ' ' A' ' 103' ' ' LEU . 97.1 Cg_endo -91.87 154.06 3.36 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.893 2.396 . . . . 0.0 112.267 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' FES . . . . . 0.546 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.886 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.074 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.963 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.696 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 7.2 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.074 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.878 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.878 ' HD2' HG12 ' A' ' 32' ' ' VAL . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 36' ' ' VAL . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 49' ' ' ARG . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.659 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.745 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.632 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.662 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 18.5 t30 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 74' ' ' THR . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 HD13 ' A' ' 71' ' ' LEU . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.416 ' HG1' ' CD ' ' A' ' 51' ' ' GLU . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.581 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.699 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.641 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.7 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.873 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 6' ' ' ILE . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_endo -55.16 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -102.96 127.82 29.09 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 86.2 Cg_endo -91.58 118.28 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.395 2.73 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.132 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.811 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.769 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.123 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.961 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.669 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.076 HD11 HD21 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.489 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.672 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.123 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.904 ' HD2' HG12 ' A' ' 32' ' ' VAL . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB1' HD11 ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.915 ' HA ' HG12 ' A' ' 36' ' ' VAL . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 36' ' ' VAL . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.627 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 60' ' ' VAL . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.111 ' NE1' HD13 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 56' ' ' TRP . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.668 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t30 -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.91 HD11 ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 2.5 mm-40 -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.539 ' HG2' HD12 ' A' ' 84' ' ' LEU . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.733 ' HG2' HG22 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.111 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.743 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.654 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 6' ' ' ILE . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.639 ' O ' HD23 ' A' ' 103' ' ' LEU . 60.5 Cg_endo -72.11 -178.06 3.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 102' ' ' PRO . 1.6 mt -149.28 175.22 2.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.705 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 103' ' ' LEU . 98.2 Cg_endo -85.97 99.63 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.792 2.328 . . . . 0.0 112.613 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.022 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.887 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.908 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG22 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.059 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.745 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.786 ' N ' HG22 ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' OE1' HG23 ' A' ' 36' ' ' VAL . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.787 ' HB2' HG12 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 50' ' ' ILE . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HD23 ' A' ' 23' ' ' LEU . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.647 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.139 ' NE1' HD13 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 62' ' ' GLU . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.755 HG22 ' HG2' ' A' ' 94' ' ' MET . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 56' ' ' TRP . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 66' ' ' ASP . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.75 ' CD2' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 84' ' ' LEU . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.644 HG22 ' NH1' ' A' ' 83' ' ' ARG . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.676 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.685 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG2' HG22 ' A' ' 59' ' ' ILE . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.965 ' C ' HD12 ' A' ' 98' ' ' ILE . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.139 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 6' ' ' ILE . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.043 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.919 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.898 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 15.2 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' HG22 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 14.5 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.884 HD11 HD21 ' A' ' 97' ' ' LEU . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.743 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.577 HG23 ' CE ' ' A' ' 24' ' ' MET . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 42' ' ' SER . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.822 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 48' ' ' CYS . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 1.051 ' CG ' HG23 ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.892 HD12 HG21 ' A' ' 60' ' ' VAL . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.136 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HG2' ' A' ' 94' ' ' MET . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.896 ' CB ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.799 ' HB1' ' HG3' ' A' ' 67' ' ' GLU . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.799 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' O ' HG23 ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 82' ' ' THR . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.051 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 67' ' ' GLU . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' CB ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.909 ' HG2' HG22 ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.719 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.136 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.023 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' VAL . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 5' ' ' PHE . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.579 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.058 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.951 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.683 ' HA ' HG22 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' SER . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.774 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.058 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.901 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.901 ' HD2' HG12 ' A' ' 32' ' ' VAL . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.819 HG22 ' CG2' ' A' ' 36' ' ' VAL . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.819 ' CG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.66 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.639 HG21 ' HB3' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.56 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 60' ' ' VAL . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.605 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.108 ' NE1' HD13 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG13 ' HA2' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 72' ' ' GLN . 2.4 t-20 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD22 ' OE2' ' A' ' 67' ' ' GLU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.449 ' HG3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.766 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.56 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.606 ' CD ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' N ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.461 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.788 HG11 HG11 ' A' ' 60' ' ' VAL . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.88 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.108 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.578 HG21 ' OD2' ' A' ' 7' ' ' ASP . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo . . . . . 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.75 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.813 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 5' ' ' PHE . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.485 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.14 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.938 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.629 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG22 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 10.2 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.54 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.728 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.763 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.14 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.744 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 44' ' ' VAL . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.864 HD12 ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 82' ' ' THR . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.034 HG22 ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.034 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.138 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB2' HG22 ' A' ' 88' ' ' VAL . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.765 ' HB2' ' CD ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.606 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.657 ' OE1' HD11 ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.493 ' ND2' ' CE ' ' A' ' 78' ' ' MET . 2.0 t-20 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.493 ' CE ' ' ND2' ' A' ' 68' ' ' ASN . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.765 ' CD ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.657 HD11 ' OE1' ' A' ' 67' ' ' GLU . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.864 ' CB ' HD12 ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.667 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.921 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.75 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.138 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HG2' HG13 ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_endo . . . . . 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.786 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.687 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.025 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.49 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.761 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.127 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ILE . 12.5 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 99' ' ' VAL . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.812 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.127 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.985 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.985 ' HD2' HG12 ' A' ' 32' ' ' VAL . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.694 ' H ' HG23 ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 42' ' ' SER . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 60' ' ' VAL . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.154 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.901 HG22 ' SD ' ' A' ' 94' ' ' MET . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.563 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 74' ' ' THR . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 22' ' ' SER . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.746 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 1.044 ' CB ' HD21 ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.786 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.046 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.154 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 6' ' ' ILE . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.001 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.897 ' CE2' HD12 ' A' ' 23' ' ' LEU . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.126 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.925 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.514 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.61 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.432 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.052 HD23 ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.126 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.751 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 36' ' ' VAL . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 35' ' ' ILE . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.715 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.678 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 ' SG ' ' A' ' 45' ' ' CYS . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.729 ' CG2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.742 ' HG3' HG23 ' A' ' 82' ' ' THR . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.016 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.016 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.118 ' NE1' HD13 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.676 HG13 ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.86 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.467 ' NE2' ' SD ' ' A' ' 78' ' ' MET . 4.1 mm-40 -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 71' ' ' LEU . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.467 ' SD ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.742 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 1.052 ' CB ' HD23 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' HB3' ' C ' ' A' ' 20' ' ' GLY . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.884 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.118 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.026 HG11 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 6' ' ' ILE . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo . . . . . 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.743 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.006 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.108 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 90' ' ' ILE . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.656 ' O ' ' HE3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HG2' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.108 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 39' ' ' CYS . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 36' ' ' VAL . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.065 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.065 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.127 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 62' ' ' GLU . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 93' ' ' SER . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 88' ' ' VAL . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 60' ' ' VAL . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.661 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 60' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.127 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.884 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ILE . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.714 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.113 HG22 HD13 ' A' ' 97' ' ' LEU . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 99' ' ' VAL . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.766 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.089 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 90' ' ' ILE . 17.1 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.677 ' N ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.718 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.089 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.766 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.807 HG13 HG11 ' A' ' 101' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 48' ' ' CYS . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.705 ' HB3' HG21 ' A' ' 36' ' ' VAL . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.032 HG22 ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.032 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.094 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 53' ' ' GLU . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.027 HG22 ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.7 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.7 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.693 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' NE ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.857 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.494 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.927 HG13 ' HE1' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.712 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 1.027 ' HG2' HG22 ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.714 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.113 HD13 HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.094 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.807 HG11 HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo . . . . . 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.997 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.59 ' N ' HG22 ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.591 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.77 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.132 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.929 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.467 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 90' ' ' ILE . 11.5 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.784 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.132 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.886 HG12 ' HD2' ' A' ' 33' ' ' PRO . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.886 ' HD2' HG12 ' A' ' 32' ' ' VAL . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 50' ' ' ILE . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.793 HG12 ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 35' ' ' ILE . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.582 ' CG ' HG23 ' A' ' 82' ' ' THR . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 60' ' ' VAL . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.803 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.121 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 53' ' ' GLU . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.76 ' CG ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.635 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.892 ' HA ' HD23 ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HE1' ' A' ' 78' ' ' MET . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' LEU . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HE1' HD21 ' A' ' 68' ' ' ASN . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.432 ' C ' ' HG1' ' A' ' 82' ' ' THR . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HD2' ' HB3' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 50' ' ' ILE . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 84' ' ' LEU . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.76 HG21 ' CG ' ' A' ' 62' ' ' GLU . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.841 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.793 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.888 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.121 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.919 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.045 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.918 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.723 ' OD1' HG21 ' A' ' 101' ' ' VAL . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.92 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.693 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 39.1 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.054 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.755 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.704 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.835 ' HG3' HG21 ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.835 HG21 ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.655 ' O ' HD13 ' A' ' 50' ' ' ILE . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.676 HG21 HD21 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.641 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.53 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.98 HG22 ' HG2' ' A' ' 94' ' ' MET . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.643 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.586 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' LEU . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 66' ' ' ASP . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.448 HG23 ' OE2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' NH1' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.585 ' N ' HG12 ' A' ' 88' ' ' VAL . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.529 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.98 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo . . . . . 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG12 ' CG1' ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.84 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 5' ' ' PHE . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 6' ' ' ILE . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.118 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.453 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 10.4 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.84 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.118 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.969 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.969 ' HD2' HG12 ' A' ' 32' ' ' VAL . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.637 HG22 HG12 ' A' ' 36' ' ' VAL . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 35' ' ' ILE . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.604 HG21 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.806 ' CG ' HG23 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.657 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.112 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.773 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.618 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.773 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 68' ' ' ASN . 1.9 t-20 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 70' ' ' LEU . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.722 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.604 ' CB ' HG21 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.668 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.997 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.765 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.927 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.112 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' ILE . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 101' ' ' VAL . 37.7 Cg_endo . . . . . 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.046 HG22 HD13 ' A' ' 97' ' ' LEU . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' ILE . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.807 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.821 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.48 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.119 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.886 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.748 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.807 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.119 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.738 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 35' ' ' ILE . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.928 ' HB2' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.928 HG22 ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HB3' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 71' ' ' LEU . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.86 HD12 ' CB ' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.642 HD12 HG21 ' A' ' 60' ' ' VAL . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.621 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.123 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' SER . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.975 HG22 ' HG2' ' A' ' 94' ' ' MET . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.642 HD22 ' O ' ' A' ' 70' ' ' LEU . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.86 ' CB ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.56 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.659 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.671 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.975 ' HG2' HG22 ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.712 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.123 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 6' ' ' ILE . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo . . . . . 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.949 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.743 ' OD2' HG21 ' A' ' 101' ' ' VAL . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.932 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 50.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.627 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.81 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.064 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.604 ' HB2' HG12 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.85 ' HA ' HG12 ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' NH1' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB3' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 50' ' ' ILE . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.045 HG22 ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.045 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.655 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.129 ' NE1' HD13 ' A' ' 98' ' ' ILE . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.866 HG13 ' HE1' ' A' ' 94' ' ' MET . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.564 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.913 ' HA ' HD23 ' A' ' 70' ' ' LEU . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' NH1' ' A' ' 49' ' ' ARG . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 57' ' ' VAL . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.736 ' NH2' HG21 ' A' ' 88' ' ' VAL . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.568 ' HB3' HD12 ' A' ' 50' ' ' ILE . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 60' ' ' VAL . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.698 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.938 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.938 HD11 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.129 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.685 ' H ' HG12 ' A' ' 99' ' ' VAL . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo . . . . . 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.886 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.074 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.963 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.696 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 1.1 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.074 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.878 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.878 ' HD2' HG12 ' A' ' 32' ' ' VAL . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 36' ' ' VAL . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 49' ' ' ARG . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.659 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.745 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.632 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.662 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 1.8 t-20 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 74' ' ' THR . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 HD13 ' A' ' 71' ' ' LEU . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.416 ' HG1' ' CD ' ' A' ' 51' ' ' GLU . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.581 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.699 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.641 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.7 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.873 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 6' ' ' ILE . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.811 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.769 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.123 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.961 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.669 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.076 HD11 HD21 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.489 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.672 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.123 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.904 ' HD2' HG12 ' A' ' 32' ' ' VAL . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB1' HD11 ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.915 ' HA ' HG12 ' A' ' 36' ' ' VAL . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 36' ' ' VAL . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.627 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 60' ' ' VAL . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.111 ' NE1' HD13 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 56' ' ' TRP . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.668 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.502 ' ND2' ' SD ' ' A' ' 78' ' ' MET . 0.8 OUTLIER -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.91 HD11 ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.502 ' SD ' ' ND2' ' A' ' 68' ' ' ASN . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.539 ' HG2' HD12 ' A' ' 84' ' ' LEU . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.733 ' HG2' HG22 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.111 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.743 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.654 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 6' ' ' ILE . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.479 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 60.5 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.7 Cg_exo . . . . . 0 N--CA 1.492 1.385 0 CA-C-O 122.312 0.88 . . . . 0.0 113.552 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -114.8 159.08 21.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.949 -1.932 . . . . 0.0 107.59 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -154.73 168.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 117.962 -1.495 . . . . 0.0 112.877 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 19.9 t -153.43 108.34 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.888 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.887 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.1 m-30 -91.29 171.87 8.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.424 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 5' ' ' PHE . 3.3 mm -150.34 162.93 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.254 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.596 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -170.75 171.21 6.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 111.268 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -91.35 13.07 18.45 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.624 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' N ' ' OD2' ' A' ' 7' ' ' ASP . 30.5 mm-40 -112.59 -34.58 5.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.182 0.515 . . . . 0.0 109.647 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.2 t -123.91 -15.02 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.737 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 65.92 18.36 66.46 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.893 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.585 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 9.4 tt0 168.86 144.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.42 0.629 . . . . 0.0 111.355 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.692 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 51.6 m-85 -150.93 61.77 0.92 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.91 133.91 31.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.848 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.09 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.74 -156.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.765 0.793 . . . . 0.0 111.532 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.908 ' H ' HG22 ' A' ' 15' ' ' VAL . 1.0 OUTLIER -156.66 162.75 39.82 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.544 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.98 -177.52 5.38 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 30.5 mm-40 -135.22 135.09 40.7 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.929 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' HG22 ' A' ' 90' ' ' ILE . 3.2 m-20 -43.41 111.5 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.208 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.35 -6.2 10.8 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.33 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -107.75 147.53 30.68 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.193 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -92.59 171.97 8.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.71 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD23 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -86.25 7.78 23.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.947 0.403 . . . . 0.0 110.554 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.475 ' SD ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -103.18 -29.18 11.47 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 6.3 mm-40 -83.78 -38.47 21.27 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.742 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.657 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.74 -55.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.815 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -74.3 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.547 -1.66 . . . . 0.0 112.295 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -32.27 5.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.511 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 26' ' ' VAL . 12.1 mt-30 -75.1 -32.87 61.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.219 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.059 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -89.22 5.82 43.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.448 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.82 3.68 74.47 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.606 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.745 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 10.7 t -55.12 146.48 39.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 123.276 0.631 . . . . 0.0 111.582 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.692 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 12.8 Cg_exo -33.72 -28.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.69 2.927 . . . . 0.0 112.498 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 46.77 32.72 6.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.506 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 35' ' ' ILE . 99.1 mt -63.52 78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.416 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -159.93 -90.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.786 ' N ' HG22 ' A' ' 36' ' ' VAL . . . 41.35 49.37 3.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.853 0.358 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' OE1' HG23 ' A' ' 36' ' ' VAL . 3.3 mt-10 -94.86 -79.77 0.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.787 ' HB2' HG12 ' A' ' 44' ' ' VAL . 14.9 p -106.28 -15.61 14.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.39 26.24 70.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.697 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.23 -1.04 76.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.752 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.92 -16.71 19.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 72.01 44.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.787 HG12 ' HB2' ' A' ' 39' ' ' CYS . 9.5 p -123.13 -9.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -120.82 169.8 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.101 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.75 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -146.26 41.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.889 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.48 -8.74 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.4 p -75.86 52.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.71 75.54 0.43 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.686 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG1' ' HB3' ' A' ' 85' ' ' SER . 5.6 mm -87.51 168.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 50' ' ' ILE . 52.9 mt-10 -141.45 116.79 10.11 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.907 HD11 HD23 ' A' ' 23' ' ' LEU . 8.4 mm -69.45 146.74 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.92 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -55.56 161.05 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 117.249 -1.781 . . . . 0.0 107.381 179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 6.5 t70 -78.14 22.56 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.647 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.82 -25.98 8.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 110.296 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.139 ' NE1' HD13 ' A' ' 98' ' ' ILE . 31.4 m95 -108.45 2.82 22.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' CG ' ' A' ' 62' ' ' GLU . 42.1 t -66.91 -36.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 118.814 -1.155 . . . . 0.0 108.73 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.49 -4.86 55.43 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.728 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.755 HG22 ' HG2' ' A' ' 94' ' ' MET . 6.4 mt -103.37 -35.23 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 121.998 0.904 . . . . 0.0 109.641 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 56' ' ' TRP . 56.9 t -89.52 -42.27 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.375 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' O ' ' NH2' ' A' ' 83' ' ' ARG . . . 80.47 84.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.695 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.566 ' HA ' ' NE ' ' A' ' 83' ' ' ARG . 13.1 mt-10 -45.78 170.23 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.405 0.622 . . . . 0.0 110.616 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.17 146.06 55.07 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.258 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.5 p-10 -53.54 175.01 0.14 Allowed Pre-proline 0 N--CA 1.436 -1.133 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.868 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -69.83 5.14 1.84 Allowed 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 123.766 2.977 . . . . 0.0 112.523 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 m-20 -90.68 -54.97 3.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.913 0.387 . . . . 0.0 110.561 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 66' ' ' ASP . 4.3 mm-40 -78.16 -21.03 50.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.85 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -86.52 -23.85 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 24.4 t70 -76.58 -53.88 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -51.64 -36.73 47.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.75 ' CD2' ' HB1' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -76.9 -31.49 56.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.789 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -77.92 -17.28 57.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -54.29 -34.3 60.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.9 p -56.84 -52.41 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.53 20.95 5.64 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.69 146.48 31.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.875 0.369 . . . . 0.0 110.792 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.54 153.9 76.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.648 2.232 . . . . 0.0 112.396 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 20.7 mtp -147.7 151.89 36.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.807 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.6 p -106.37 -173.47 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.205 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 119.96 -0.76 13.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.612 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.48 107.75 10.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 0.0 110.994 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH1' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -158.92 151.62 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.0 110.894 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 84' ' ' LEU . 5.5 mp -51.81 91.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -54.26 -45.43 72.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 p -51.3 -25.56 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' O ' ' CE2' ' A' ' 89' ' ' PHE . 7.6 tt0 -91.29 -1.05 57.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.543 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG22 ' NH1' ' A' ' 83' ' ' ARG . 21.3 t -99.01 160.38 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-O 120.449 0.166 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 37.7 m-85 -152.89 140.45 19.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.676 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.4 mm -59.92 147.21 9.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.422 -1.717 . . . . 0.0 113.512 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.685 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -161.04 156.93 21.82 Favored Pre-proline 0 N--CA 1.429 -1.488 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 47.3 Cg_exo -59.23 23.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.18 1.92 . . . . 0.0 112.896 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.44 -26.77 7.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.692 1.197 . . . . 0.0 110.32 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG2' HG22 ' A' ' 59' ' ' ILE . 3.9 mtp -125.67 51.99 1.69 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.98 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -91.49 130.8 37.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.561 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 80.72 33.43 30.59 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.965 ' C ' HD12 ' A' ' 98' ' ' ILE . 3.4 mt -64.4 155.04 33.76 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.843 0.83 . . . . 0.0 113.023 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.139 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.7 OUTLIER -125.85 115.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.692 177.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -95.5 -179.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 99' ' ' VAL . 5.6 mtt180 -166.09 151.18 8.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.138 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 6' ' ' ILE . 57.6 t -117.1 133.14 23.17 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.892 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HG3' ' O ' ' A' ' 49' ' ' ARG . 70.3 Cg_endo -73.21 -177.9 3.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.746 2.298 . . . . 0.0 112.52 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -79.38 178.41 2.33 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.0 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' N ' ' HG ' ' A' ' 103' ' ' LEU . 51.6 Cg_exo -53.08 92.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.744 2.296 . . . . 0.0 112.012 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.162 -179.795 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 53.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 122.042 0.768 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.757 ' O ' HG23 ' A' ' 3' ' ' VAL . 21.0 ttt180 -115.69 163.97 15.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.55 -1.659 . . . . 0.0 107.389 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.043 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -160.92 166.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.839 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.8 t -149.73 109.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.778 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.919 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -91.17 173.47 7.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.298 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.919 HD13 ' O ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -153.62 160.83 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.799 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.568 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.2 t70 -170.47 171.69 6.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.468 0.651 . . . . 0.0 111.927 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.0 -14.21 58.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.234 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' A' ' 7' ' ' ASP . 1.9 mt-30 -90.03 6.5 42.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 14.0 t -170.59 -32.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.25 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 81.33 19.59 66.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.616 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.3 tt0 171.65 142.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.348 0.594 . . . . 0.0 111.408 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 49.9 m-85 -151.47 62.78 0.88 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.066 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.13 138.68 15.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.864 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.1 p -161.62 -155.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.956 0.884 . . . . 0.0 112.065 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.898 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -157.96 163.73 37.53 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.41 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -170.82 3.43 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.908 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 15.2 mt-30 -143.81 128.32 18.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' HG22 ' A' ' 90' ' ' ILE . 40.5 m-20 -34.86 107.37 0.05 Allowed 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.24 0.543 . . . . 0.0 110.44 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.19 -0.49 11.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 14.5 mt-30 -110.23 142.01 42.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.833 0.349 . . . . 0.0 110.467 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 89' ' ' PHE . 1.3 p -89.4 173.24 8.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.884 HD11 HD21 ' A' ' 97' ' ' LEU . 1.4 mm? -84.73 9.3 14.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.002 0.43 . . . . 0.0 110.435 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.65 -26.56 12.27 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.12 -41.37 14.79 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.34 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.14 -56.57 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.29 -74.48 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.231 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.18 -31.39 5.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.815 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 26' ' ' VAL . 29.1 mm100 -76.65 -32.5 58.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.022 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.61 6.74 36.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.793 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.44 15.84 75.33 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.743 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 20.4 t -71.17 143.2 88.14 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 13.7 Cg_endo -55.87 -155.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.568 2.179 . . . . 0.0 110.062 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 35' ' ' ILE . . . 39.59 21.94 0.03 OUTLIER Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.656 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -37.8 159.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.334 0.567 . . . . 0.0 110.272 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.577 HG23 ' CE ' ' A' ' 24' ' ' MET . 4.3 p -26.67 130.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.885 0.374 . . . . 0.0 111.803 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' HB3' ' S2 ' ' A' ' 106' ' ' FES . . . -78.48 -159.56 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.459 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.99 -56.3 9.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.167 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 0.5 OUTLIER -63.04 -36.63 84.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 30.46 76.88 0.03 OUTLIER Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.349 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.31 21.4 20.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.132 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.823 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -132.34 2.38 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.125 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.474 ' HA ' ' S1 ' ' A' ' 106' ' ' FES . 26.2 p 36.06 35.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' SER . 59.2 t -99.78 -9.53 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.186 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -116.37 -164.37 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.89 21.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.294 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.84 5.42 40.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.055 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.822 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.9 p -94.66 40.15 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.971 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -52.33 112.56 0.83 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.269 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 48' ' ' CYS . 2.0 mp -147.21 153.04 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.098 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.051 ' CG ' HG23 ' A' ' 82' ' ' THR . 1.2 mp0 -140.65 133.92 29.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.824 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.892 HD12 HG21 ' A' ' 60' ' ' VAL . 8.4 mm -69.03 147.75 11.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.815 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.652 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -56.53 162.26 2.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.722 179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -79.04 20.8 0.47 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.73 -26.02 8.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.264 0.554 . . . . 0.0 109.859 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.136 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.4 m95 -109.28 4.77 23.04 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.08 -37.11 79.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.709 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.88 -3.33 50.93 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.889 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' SER . 7.1 mt -106.51 -34.98 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.299 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HG2' ' A' ' 94' ' ' MET . 53.2 t -87.84 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.065 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 48.49 68.0 1.44 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.896 ' CB ' HG21 ' A' ' 88' ' ' VAL . 22.9 mt-10 -48.09 -117.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.974 -0.613 . . . . 0.0 112.232 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.799 ' HB1' ' HG3' ' A' ' 67' ' ' GLU . . . -85.29 -175.12 5.57 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.494 0.664 . . . . 0.0 112.565 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.63 179.35 1.5 Allowed Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.448 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 20.7 Cg_exo -66.82 -0.9 5.12 Favored 'Trans proline' 0 C--N 1.331 -0.387 0 C-N-CA 123.848 3.032 . . . . 0.0 112.507 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.0 -53.52 4.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.137 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.799 ' HG3' ' HB1' ' A' ' 63' ' ' ALA . 11.3 mm-40 -59.34 -25.47 64.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -89.97 -28.91 18.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.475 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 6.8 t70 -54.23 -48.01 71.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.24 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 71' ' ' LEU . 3.0 pp -51.08 -39.24 55.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.432 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' O ' HG23 ' A' ' 74' ' ' THR . 4.6 mt -72.68 -40.97 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.368 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -54.86 -39.75 68.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.163 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.72 -27.01 58.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.337 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 71' ' ' LEU . 43.5 p -50.01 -49.7 49.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.55 -29.89 3.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.042 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.86 124.56 35.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.559 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.76 -168.95 0.14 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.765 2.31 . . . . 0.0 112.492 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.584 ' HB3' HG21 ' A' ' 82' ' ' THR . 22.8 mtm -124.97 -166.49 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.801 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 82' ' ' THR . 5.1 p -106.09 -160.66 0.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.69 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.85 130.36 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.79 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.57 12.85 82.32 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.641 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.051 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -77.67 123.16 26.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 111.618 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HE ' ' N ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -170.92 155.09 4.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.009 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 67' ' ' GLU . 65.0 mt -45.7 127.3 7.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 0.0 110.451 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -89.74 -32.34 17.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.393 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 24' ' ' MET . 1.5 p -86.65 21.78 2.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -127.06 -11.2 5.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.415 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.896 HG21 ' CB ' ' A' ' 62' ' ' GLU . 28.3 t -112.41 160.62 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 22' ' ' SER . 55.7 m-85 -147.88 144.15 27.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.3 mm -47.11 163.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.092 -1.413 . . . . 0.0 112.78 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.2 168.69 0.81 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 Cg_exo -66.15 45.82 0.2 Allowed 'Trans proline' 0 C--N 1.335 -0.176 0 C-N-CA 122.386 2.057 . . . . 0.0 111.11 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.62 -36.96 0.42 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.818 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.909 ' HG2' HG22 ' A' ' 60' ' ' VAL . 50.2 mtp -112.85 45.26 1.36 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.65 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.719 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -89.02 125.41 34.98 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.603 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 75.4 29.01 60.64 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.96 149.16 43.59 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.551 0.691 . . . . 0.0 112.205 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.136 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.9 OUTLIER -114.42 126.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.559 -178.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.659 ' CG2' ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -98.52 179.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.328 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.5 mmm-85 -164.05 144.02 8.08 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.258 0.349 . . . . 0.0 111.155 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 6' ' ' ILE . 2.6 t -138.72 79.12 29.4 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 121.079 0.466 . . . . 0.0 110.485 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.46 -178.69 4.65 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 123.077 2.518 . . . . 0.0 112.927 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -79.9 125.27 82.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.013 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 51.0 Cg_exo -54.28 98.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.707 2.271 . . . . 0.0 112.368 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.709 ' S2 ' ' HB3' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 37.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.808 0.67 . . . . 0.0 112.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.15 164.89 14.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.772 -1.558 . . . . 0.0 107.927 178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.023 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -161.8 165.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 118.196 -1.402 . . . . 0.0 113.014 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 99' ' ' VAL . 18.0 t -149.74 110.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.611 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.835 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -89.25 173.93 8.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.538 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 5' ' ' PHE . 12.4 mm -151.8 163.29 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.397 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.579 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.4 t0 -171.14 -166.78 0.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.86 0.362 . . . . 0.0 111.362 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.17 -2.85 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.187 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -89.63 -39.08 13.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.689 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 8.6 t -128.53 -2.01 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.797 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.45 18.91 52.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.747 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.8 tt0 169.81 144.24 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.493 0.663 . . . . 0.0 111.474 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 35.8 m-85 -146.97 57.33 1.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.548 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -47.49 143.2 3.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.513 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.058 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -168.02 -154.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.068 0.937 . . . . 0.0 112.595 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.951 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.1 m-20 -156.45 164.6 38.06 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.241 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -144.12 -174.34 4.26 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.562 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 57.7 mm-40 -137.57 137.31 38.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.822 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.683 ' HA ' HG22 ' A' ' 90' ' ' ILE . 22.1 m-20 -43.35 107.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.342 0.592 . . . . 0.0 110.436 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.33 -0.36 11.42 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.509 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -115.75 153.14 31.93 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.309 0.554 . . . . 0.0 110.67 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 8.7 p -101.46 176.28 5.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.536 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -80.86 4.66 18.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.798 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.5 ttp -93.14 -35.34 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.391 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 22' ' ' SER . 3.0 pp20? -83.09 -39.68 20.83 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.984 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.729 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -49.54 -58.37 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.379 -1.328 . . . . 0.0 107.667 178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.774 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -28.55 -72.86 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.435 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.54 -31.91 7.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.163 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' VAL . 3.0 mm-40 -76.85 -32.25 57.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.058 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.15 4.9 43.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.515 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.89 -7.37 70.62 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.094 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.901 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.2 t -49.8 160.14 0.66 Allowed Pre-proline 0 N--CA 1.453 -0.278 0 C-N-CA 123.167 0.587 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.901 ' HD2' HG12 ' A' ' 32' ' ' VAL . 10.6 Cg_exo -76.08 7.36 3.31 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.85 3.033 . . . . 0.0 112.544 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.43 32.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.844 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.819 HG22 ' CG2' ' A' ' 36' ' ' VAL . 3.0 mp 35.59 -90.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.646 0.26 . . . . 0.0 111.328 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.819 ' CG2' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -171.16 127.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 0.0 111.329 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.52 110.28 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.969 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -95.64 -65.53 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.315 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 p -58.64 -36.43 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.318 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.6 28.97 12.79 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.506 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 46.33 6.18 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.909 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . 6.3 p -138.99 23.3 2.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.99 0.424 . . . . 0.0 110.454 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 42' ' ' SER . 0.2 OUTLIER 40.82 63.32 1.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.113 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 42' ' ' SER . 3.0 t -135.6 4.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.444 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.66 ' SG ' HG22 ' A' ' 47' ' ' THR . 0.7 OUTLIER -139.74 -173.19 3.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.957 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.49 20.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.66 HG22 ' SG ' ' A' ' 45' ' ' CYS . 14.8 t -81.35 -19.54 42.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' HB3' ' S2 ' ' A' ' 106' ' ' FES . 30.0 p -79.87 52.23 1.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.638 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -71.53 96.47 1.53 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.355 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.639 HG21 ' HB3' ' A' ' 85' ' ' SER . 2.5 tt -115.27 170.45 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.196 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.56 ' CG ' HG23 ' A' ' 82' ' ' THR . 12.3 mt-10 -148.62 116.81 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 HD12 HG21 ' A' ' 60' ' ' VAL . 5.9 mm -67.96 143.92 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.605 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.73 159.91 2.06 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 117.636 -1.626 . . . . 0.0 107.967 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.539 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 10.7 m-20 -77.06 21.37 0.23 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.88 -25.51 8.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 0.0 110.285 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.108 ' NE1' HD13 ' A' ' 98' ' ' ILE . 35.1 m95 -106.1 -9.23 17.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG13 ' HA2' ' A' ' 81' ' ' GLY . 16.1 t -52.75 -43.53 45.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.962 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -3.49 40.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.182 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -100.86 -38.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.539 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 30.8 t -88.26 -38.88 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.439 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.15 84.07 0.74 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.623 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HA2' ' A' ' 81' ' ' GLY . 6.0 mt-10 -46.81 150.04 0.77 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.5 0.667 . . . . 0.0 110.333 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -50.07 161.18 0.28 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.858 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 3.6 p30 -74.3 -174.33 0.35 Allowed Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.283 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 45.6 Cg_exo -55.13 -13.44 6.8 Favored 'Trans proline' 0 C--N 1.333 -0.257 0 C-N-CA 123.322 2.681 . . . . 0.0 112.732 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 62.7 m-20 -72.47 -41.14 66.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.583 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 10.5 tm-20 -74.78 -56.19 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.33 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 72' ' ' GLN . 2.4 t-20 -50.46 -35.19 27.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.242 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.14 -39.65 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.242 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.14 -44.89 94.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.473 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD22 ' OE2' ' A' ' 67' ' ' GLU . 7.2 mp -78.6 -35.26 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.682 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.449 ' HG3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -61.57 -22.92 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -35.92 80.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 p -58.27 -53.93 52.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.952 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.1 3.72 15.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.586 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -94.16 151.61 39.71 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.378 . . . . 0.0 110.834 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 18.5 Cg_endo -59.67 -171.9 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.674 2.25 . . . . 0.0 112.212 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -157.53 165.96 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.941 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 -174.44 3.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.767 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 125.25 29.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.766 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 88.6 3.72 77.35 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.957 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.56 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.59 103.17 4.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.709 0.29 . . . . 0.0 111.132 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.606 ' CD ' HG23 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -153.86 151.08 29.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD13 ' S1 ' ' A' ' 106' ' ' FES . 15.1 mt -42.19 122.6 2.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.59 -21.41 66.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.447 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.461 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 7.7 p -99.09 30.38 3.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.448 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -132.4 -20.65 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.788 HG11 HG11 ' A' ' 60' ' ' VAL . 8.5 t -98.12 115.77 39.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 O-C-N 122.464 -0.148 . . . . 0.0 110.939 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 6.0 m-30 -111.02 133.44 53.41 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.844 0.83 . . . . 0.0 112.878 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 19' ' ' ASP . 1.4 mm -48.55 163.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.951 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 179.91 167.85 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.32 43.85 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.259 0 C-N-CA 122.231 1.954 . . . . 0.0 111.4 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -139.71 -29.06 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.34 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.8 mtp -121.13 44.67 2.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 33.6 m-20 -90.14 127.09 36.02 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.551 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.02 27.49 66.42 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.88 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.07 161.35 30.13 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.575 0.703 . . . . 0.0 111.773 -178.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.108 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -117.3 131.39 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.582 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -118.89 149.3 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.416 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.98 152.67 46.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.446 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.578 HG21 ' OD2' ' A' ' 7' ' ' ASP . 94.7 t -105.18 126.16 31.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' VAL . 86.5 Cg_exo -48.38 -166.59 0.0 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 122.852 2.368 . . . . 0.0 113.451 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.88 146.42 32.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.788 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 105' ' ' ALA . 29.8 Cg_endo -61.99 -170.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.933 2.422 . . . . 0.0 112.482 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.191 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.438 ' S1 ' HD13 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.75 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 122.033 0.764 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.704 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -115.37 159.43 21.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.279 -1.782 . . . . 0.0 107.151 177.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -157.83 164.76 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 118.11 -1.436 . . . . 0.0 112.763 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.8 t -149.69 109.77 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.334 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.813 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.3 m-30 -89.54 174.5 7.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.329 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 5' ' ' PHE . 18.4 mm -152.3 160.62 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.007 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 t0 -171.3 -171.86 1.01 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.087 0.47 . . . . 0.0 111.317 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -0.91 24.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -89.93 -39.81 12.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.386 . . . . 0.0 110.727 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -128.22 -3.04 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.83 18.25 59.31 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.922 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 52.4 tt0 168.68 144.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.373 0.606 . . . . 0.0 111.588 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.704 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 59.6 m-85 -147.23 59.86 1.17 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.082 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.81 142.36 8.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.14 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.61 -154.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-O 121.902 0.858 . . . . 0.0 112.508 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.938 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -158.12 163.51 37.55 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.626 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.629 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.5 -172.44 3.62 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.702 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 35.9 mt-30 -142.15 128.57 20.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.419 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' HG22 ' A' ' 90' ' ' ILE . 7.1 m-20 -36.55 109.94 0.1 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.42 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.93 -1.29 11.89 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 10.2 mt-30 -116.58 153.38 32.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.895 0.378 . . . . 0.0 110.379 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 71.9 p -102.34 -176.46 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.079 0.466 . . . . 0.0 111.388 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -86.8 8.95 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.361 179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.54 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -96.86 -31.51 12.56 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.413 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -88.68 -40.05 13.56 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.728 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -49.62 -58.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 118.339 -1.344 . . . . 0.0 107.454 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.763 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.93 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.472 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.52 ' CG2' ' CD1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -48.28 -30.67 5.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.901 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -77.47 -31.9 54.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.571 178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.14 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.87 6.22 40.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.937 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.16 3.72 85.55 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.128 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.744 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.6 t -58.54 144.4 79.25 Favored Pre-proline 0 N--CA 1.45 -0.444 0 C-N-CA 123.096 0.558 . . . . 0.0 111.729 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.704 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 34.1 Cg_exo -27.01 61.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 1 C-N-CA 126.683 4.922 . . . . 0.0 115.472 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 18.87 46.52 0.01 OUTLIER Glycine 0 C--N 1.323 -0.154 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.495 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 36' ' ' VAL . 52.5 mt 52.14 166.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.995 0.398 . . . . 0.0 110.994 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -113.99 -25.08 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.168 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' CB ' ' S1 ' ' A' ' 106' ' ' FES . . . -83.01 136.57 34.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.169 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.53 -7.55 37.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -85.16 14.19 5.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 111.09 -179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.65 31.31 0.69 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.763 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' N ' ' HE3' ' A' ' 24' ' ' MET . . . 72.37 18.23 78.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.738 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -74.81 0.65 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.177 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 t 69.98 59.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 44' ' ' VAL . 5.1 t -150.41 17.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 1.4 p -146.3 -179.73 6.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 111.154 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.97 15.59 2.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.743 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -13.38 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.9 p -79.99 51.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.45 59.18 4.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.669 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.864 HD12 ' CB ' ' A' ' 85' ' ' SER . 3.2 mt -77.88 150.73 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.202 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 82' ' ' THR . 22.0 mt-10 -128.05 122.46 32.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.079 0.466 . . . . 0.0 111.925 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.034 HG22 ' OE1' ' A' ' 53' ' ' GLU . 6.8 mm -69.07 147.83 11.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.034 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.63 -179.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 117.707 -1.597 . . . . 0.0 108.575 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -93.5 22.79 5.04 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.68 -0.637 . . . . 0.0 112.136 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.58 -29.56 6.79 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.708 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.138 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -108.22 -2.5 19.3 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 40.1 t -58.24 -39.84 75.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.329 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -4.37 47.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.073 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.9 mt -102.11 -39.62 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.537 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.4 t -92.64 -78.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.39 53.08 0.01 OUTLIER Glycine 0 C--N 1.34 0.791 0 O-C-N 123.586 0.553 . . . . 0.0 113.217 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' HB2' HG22 ' A' ' 88' ' ' VAL . 6.0 mm-40 -76.6 -21.1 56.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.765 ' HB2' ' CD ' ' A' ' 83' ' ' ARG . . . -55.54 147.63 17.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.451 0.643 . . . . 0.0 111.814 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.606 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.94 -179.3 1.12 Allowed Pre-proline 0 N--CA 1.433 -1.302 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 177.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.606 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.7 Cg_exo -68.63 5.97 1.12 Allowed 'Trans proline' 0 C--N 1.322 -0.853 0 C-N-CA 123.238 2.626 . . . . 0.0 111.799 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -91.66 -50.89 5.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.426 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.657 ' OE1' HD11 ' A' ' 84' ' ' LEU . 7.6 tp10 -51.62 -35.17 40.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.493 ' ND2' ' CE ' ' A' ' 78' ' ' MET . 2.0 t-20 -83.37 -27.65 29.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 18.9 t70 -80.81 -48.99 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.966 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' THR . 0.4 OUTLIER -50.82 -37.44 42.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.23 -42.14 23.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -24.32 64.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.87 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.2 p -78.82 -19.34 52.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' LEU . 25.2 p -87.67 -36.0 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.62 5.84 18.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -100.46 122.2 50.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.823 0.344 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.98 178.39 6.55 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.493 ' CE ' ' ND2' ' A' ' 68' ' ' ASN . 5.5 mtm -137.42 -158.54 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.417 ' OG1' ' CD ' ' A' ' 51' ' ' GLU . 12.9 p -134.98 -174.69 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.26 114.48 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.166 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 97.21 9.55 55.49 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.745 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.98 141.29 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.722 0.296 . . . . 0.0 110.855 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.765 ' CD ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -170.42 136.0 1.28 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.949 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.657 HD11 ' OE1' ' A' ' 67' ' ' GLU . 15.8 mt -52.55 123.4 10.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.694 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.864 ' CB ' HD12 ' A' ' 50' ' ' ILE . 55.5 p -75.51 -4.77 41.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.0 p -108.14 11.02 27.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 84' ' ' LEU . 56.7 mm-40 -132.34 -11.15 3.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.069 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 22' ' ' SER . 17.7 t -99.2 110.1 25.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 4.6 m-30 -110.42 134.29 52.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.828 0.823 . . . . 0.0 113.092 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -46.83 162.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.218 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -177.47 168.23 1.15 Allowed Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.1 Cg_exo -65.73 45.47 0.18 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.437 2.091 . . . . 0.0 111.073 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -141.88 -36.08 0.43 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.697 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.921 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.04 43.32 1.6 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.701 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.75 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.21 125.53 35.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 77.17 26.87 61.0 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.81 152.36 42.73 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.731 -0.734 . . . . 0.0 112.438 -177.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.138 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -112.93 137.07 47.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.694 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.03 154.75 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HG2' HG13 ' A' ' 6' ' ' ILE . 56.6 mtt180 -140.11 163.04 33.77 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.213 0.53 . . . . 0.0 111.787 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 102' ' ' PRO . 96.9 t -120.38 140.89 30.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.76 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_endo -54.74 -170.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.839 2.359 . . . . 0.0 112.346 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.3 mp -111.64 162.52 20.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 168.38 22.84 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.998 2.465 . . . . 0.0 112.087 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.315 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.52 ' S1 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.786 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.5 Cg_exo . . . . . 0 N--CA 1.491 1.362 0 CA-C-O 121.843 0.684 . . . . 0.0 113.184 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.687 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -110.3 159.0 17.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.555 178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.025 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -157.97 171.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 C-N-CA 118.158 -1.417 . . . . 0.0 112.372 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.9 t -157.0 107.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.382 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.812 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -88.91 172.22 9.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.328 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.2 mp -155.13 161.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 123.774 0.671 . . . . 0.0 110.668 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 6' ' ' ILE . 20.6 t0 -172.19 179.14 2.69 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.274 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 3.8 tt0 -88.26 -3.45 58.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.084 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.49 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 11.7 mm100 -89.8 -32.05 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.539 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.499 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -138.82 2.53 2.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.669 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.81 18.57 8.57 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.507 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 23.1 tt0 168.74 141.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.256 0.55 . . . . 0.0 110.646 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.761 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 29.7 m-85 -145.37 54.97 1.2 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.351 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -44.57 143.53 1.32 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.041 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.127 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -169.82 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 122.059 0.933 . . . . 0.0 112.0 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.9 OUTLIER -156.92 163.7 38.86 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.381 -1.282 . . . . 0.0 107.579 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.21 -170.99 3.01 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.817 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 44.5 mt-30 -146.9 126.08 12.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.267 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.6 m-20 -36.18 110.14 0.1 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.353 0.597 . . . . 0.0 110.356 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.15 -0.55 11.61 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.456 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 90' ' ' ILE . 12.5 mt-30 -114.76 150.81 34.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.805 0.336 . . . . 0.0 110.211 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 19.0 p -99.95 168.18 10.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 99' ' ' VAL . 0.9 OUTLIER -77.03 1.78 16.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 110.217 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.489 ' HB2' ' CB ' ' A' ' 85' ' ' SER . 2.7 ttp -94.29 -36.39 12.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 26' ' ' VAL . 2.1 tp10 -78.98 -40.62 31.16 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.206 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.49 -56.93 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 C-N-CA 118.224 -1.391 . . . . 0.0 107.321 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.812 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.16 -74.11 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.311 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -31.99 6.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.958 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 mm100 -77.77 -30.51 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.833 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.127 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 4.98 45.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.408 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.87 -11.89 63.32 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.985 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.5 t -49.97 160.72 0.62 Allowed Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 123.198 0.599 . . . . 0.0 110.352 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.985 ' HD2' HG12 ' A' ' 32' ' ' VAL . 23.3 Cg_exo -68.89 -3.68 11.88 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 123.715 2.944 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 32.13 69.77 0.12 Allowed Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.11 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 34' ' ' GLY . 1.7 mt -34.18 91.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.805 0.336 . . . . 0.0 110.7 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.694 HG23 ' H ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -59.3 -71.94 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.773 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.694 ' H ' HG23 ' A' ' 36' ' ' VAL . . . 86.12 -168.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.771 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -85.6 -58.65 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.155 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -60.47 -36.58 78.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.922 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 31.62 62.11 0.26 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.037 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 27.66 9.8 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.809 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 44' ' ' VAL . 3.7 m -136.14 6.96 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.616 0.246 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t 43.3 69.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 42' ' ' SER . 19.8 t -148.05 13.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.255 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -139.68 179.63 6.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.89 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.13 24.3 1.63 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.158 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -92.45 -6.25 50.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 50' ' ' ILE . 31.8 p -89.15 21.8 3.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.734 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -50.87 83.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.005 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 48' ' ' CYS . 10.1 tp -82.41 154.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.588 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.29 110.25 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.091 0.472 . . . . 0.0 111.754 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 HG21 ' A' ' 60' ' ' VAL . 8.8 mm -69.5 141.55 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.58 160.11 1.9 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 117.026 -1.87 . . . . 0.0 107.577 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -75.6 20.67 0.16 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.63 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.28 -26.3 8.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.194 0.521 . . . . 0.0 110.133 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.154 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.0 m95 -107.31 7.07 29.04 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.4 t -69.87 -36.29 68.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -81.2 -5.73 58.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.588 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.3 mt -102.98 -37.43 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.504 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.901 HG22 ' SD ' ' A' ' 94' ' ' MET . 55.9 t -91.57 -82.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.372 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.55 49.58 0.01 OUTLIER Glycine 0 C--N 1.34 0.777 0 O-C-N 123.537 0.523 . . . . 0.0 113.007 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.537 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 16.1 mm-40 -76.81 -17.63 58.9 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -49.35 141.86 8.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.625 0.726 . . . . 0.0 111.906 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.563 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -91.22 171.89 7.44 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.818 177.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.2 Cg_endo -61.38 4.17 0.28 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.882 2.388 . . . . 0.0 112.333 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 64' ' ' ASN . 76.8 m-20 -92.61 -66.74 0.9 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 121.118 0.485 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.48 -54.56 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -36.08 67.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -80.9 -44.58 18.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.17 -50.59 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 74' ' ' THR . 0.8 OUTLIER -68.44 -45.13 73.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -35.06 61.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -20.6 59.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.1 p -73.36 -24.86 60.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.069 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 77' ' ' PRO . . . 105.82 -20.64 35.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.96 88.86 10.62 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.794 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 75' ' ' GLY . 52.4 Cg_exo -54.8 -173.35 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.724 2.283 . . . . 0.0 112.24 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.92 -167.99 1.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -110.36 -167.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.553 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.83 119.03 22.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.399 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 87.49 7.2 76.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.688 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 146.75 42.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.035 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.703 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.89 -165.6 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.9 mp -114.98 109.36 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.668 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 24' ' ' MET . 15.6 p -58.51 -26.48 63.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.037 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.17 12.79 33.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.294 . . . . 0.0 110.778 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 2.1 tp-100 -126.36 -22.21 4.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.725 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 22' ' ' SER . 35.3 t -101.15 135.47 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.0 m-85 -128.51 158.12 39.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.538 0.685 . . . . 0.0 112.731 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.746 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.4 mm -66.9 156.19 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.625 -1.171 . . . . 0.0 113.333 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -178.98 169.18 0.81 Allowed Pre-proline 0 N--CA 1.439 -0.993 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 91' ' ' ASP . 18.7 Cg_exo -66.65 43.62 0.19 Allowed 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 121.793 1.662 . . . . 0.0 111.309 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -144.45 14.0 1.59 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.327 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 1.044 ' CB ' HD21 ' A' ' 97' ' ' LEU . 10.4 mtm -165.53 47.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.258 -178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.786 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -92.84 127.64 38.42 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.627 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.55 31.74 44.42 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.159 -1.019 . . . . 0.0 110.968 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.046 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.0 mt -63.51 165.41 7.99 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.355 1.074 . . . . 0.0 113.782 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.154 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -132.64 110.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 113.425 -1.716 . . . . 0.0 109.888 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.907 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.78 154.4 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 30.1 mtp180 -140.64 166.98 23.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.171 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 6' ' ' ILE . 78.1 t -123.7 117.22 27.6 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.957 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.43 -179.53 5.39 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.694 2.263 . . . . 0.0 112.659 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -94.0 132.52 29.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.719 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -84.44 -179.69 4.0 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.901 2.401 . . . . 0.0 112.298 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.988 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.429 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.728 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 48.2 Cg_exo . . . . . 0 N--CA 1.491 1.351 0 CA-C-O 121.856 0.69 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 3' ' ' VAL . 3.6 tpt180 -116.37 160.66 20.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.699 -1.592 . . . . 0.0 107.626 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.001 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -159.78 165.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 C-N-CA 117.998 -1.481 . . . . 0.0 112.585 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 99' ' ' VAL . 9.1 t -150.53 110.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.52 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.897 ' CE2' HD12 ' A' ' 23' ' ' LEU . 3.1 m-30 -90.43 173.81 7.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.402 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.91 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.4 mm -154.46 164.07 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.795 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 6' ' ' ILE . 4.0 t0 -170.85 -169.28 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.878 0.371 . . . . 0.0 111.355 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 4.7 tt0 -106.36 -0.59 24.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -89.62 -40.08 12.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.072 0.463 . . . . 0.0 110.392 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -125.11 -19.53 5.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.998 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 79.09 17.87 75.85 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.41 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 23.7 tt0 168.57 143.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.445 0.64 . . . . 0.0 111.599 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 63.3 m-85 -148.27 59.53 1.1 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.122 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.63 143.45 7.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.575 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.126 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -167.27 -153.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 122.107 0.955 . . . . 0.0 112.272 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.925 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -161.55 162.54 30.26 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.972 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.67 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -141.21 -173.89 3.86 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.539 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.514 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 4.3 mm-40 -140.43 137.85 34.26 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.984 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.61 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -43.4 107.42 0.08 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 122.23 3.32 9.7 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.272 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.432 ' OE1' ' HG3' ' A' ' 18' ' ' GLN . 10.1 mt-30 -118.89 143.96 46.68 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.937 0.369 . . . . 0.0 110.625 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -97.56 179.25 4.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.582 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.052 HD23 ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -78.74 -0.07 28.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.622 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -35.33 14.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -81.99 -41.14 21.15 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.238 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.669 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -52.64 -58.57 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 118.037 -1.465 . . . . 0.0 107.699 178.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.769 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.9 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.202 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -30.61 5.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.904 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 28.1 mm-40 -79.56 -31.3 41.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.791 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.126 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.17 7.05 33.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.802 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.37 11.37 85.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.075 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.751 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 4.7 t -69.7 141.41 90.16 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 6.3 Cg_endo -52.17 34.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.895 1 C-N-CA 125.4 4.067 . . . . 0.0 116.132 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 18.73 57.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.743 -0.476 . . . . 0.0 114.007 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 36' ' ' VAL . 28.3 mm 3.1 -70.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 35' ' ' ILE . 1.3 p -178.4 -64.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.715 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 54.13 96.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.92 -61.54 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.678 ' HB2' HG23 ' A' ' 44' ' ' VAL . 15.4 p -57.7 -25.9 60.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.245 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.18 47.48 36.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.503 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.42 2.73 88.12 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.792 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m -74.93 -3.57 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 110.998 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 m 52.95 64.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.03 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.678 HG23 ' HB2' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -154.64 19.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.347 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -144.91 175.28 10.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.064 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.84 15.62 2.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.425 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 ' SG ' ' A' ' 45' ' ' CYS . 6.3 t -75.89 -9.47 58.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.965 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 24.3 p -88.65 53.23 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.719 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -69.02 86.66 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.023 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.729 ' CG2' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -108.4 170.42 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.742 ' HG3' HG23 ' A' ' 82' ' ' THR . 12.6 mt-10 -146.37 121.34 10.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.016 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.4 mm -69.22 147.72 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.016 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -55.64 -177.9 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 117.926 -1.509 . . . . 0.0 108.742 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.96 21.23 6.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.34 -30.69 6.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.404 0.621 . . . . 0.0 110.408 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.118 ' NE1' HD13 ' A' ' 98' ' ' ILE . 23.6 m95 -105.3 2.58 29.06 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.676 HG13 ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -66.09 -37.2 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 118.866 -1.134 . . . . 0.0 108.733 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -80.34 -3.98 51.66 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.579 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.1 mt -101.63 -40.08 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.488 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.986 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.7 t -91.35 -75.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.534 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.04 52.14 0.01 OUTLIER Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 113.44 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mm-40 -79.27 -18.82 52.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.893 0.378 . . . . 0.0 111.478 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.86 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -60.84 148.33 39.71 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.452 0.644 . . . . 0.0 112.041 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.8 p30 -90.59 178.8 1.69 Allowed Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.617 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 4.1 Cg_exo -73.62 12.81 0.83 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.377 2.718 . . . . 0.0 112.022 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -92.24 -61.81 1.54 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.131 0.491 . . . . 0.0 111.035 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.86 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 1.5 pp20? -52.55 -33.5 45.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.18 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -74.65 -32.56 62.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 69' ' ' ASP . 34.0 t0 -81.67 -47.48 12.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.948 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.3 tt -51.75 -53.11 43.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -63.19 -47.7 81.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.883 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.467 ' NE2' ' SD ' ' A' ' 78' ' ' MET . 4.1 mm-40 -54.01 -33.32 56.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.801 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -7.86 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 71' ' ' LEU . 8.0 p -87.47 -44.96 10.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.729 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.52 3.56 6.56 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.501 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -99.39 105.96 36.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -46.69 161.06 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.72 2.28 . . . . 0.0 112.136 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.467 ' SD ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -121.81 175.03 6.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.948 0.404 . . . . 0.0 111.11 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -143.45 131.58 21.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.429 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -35.41 102.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.327 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.6 -25.35 7.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.949 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.742 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -65.79 118.15 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.805 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 88' ' ' VAL . 0.1 OUTLIER -165.06 174.03 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 2.1 mt -79.96 76.66 6.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 1.052 ' CB ' HD23 ' A' ' 23' ' ' LEU . 1.3 m -59.55 -25.02 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.055 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.2 p -52.46 -23.14 5.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.22 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -106.72 -1.98 22.1 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.295 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.8 t -94.04 113.36 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' HB3' ' C ' ' A' ' 20' ' ' GLY . 9.0 m-30 -104.99 136.68 44.02 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.67 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.5 mm -44.36 160.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 114.031 -1.44 . . . . 0.0 112.483 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -176.07 166.99 1.64 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.48 42.31 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 111.88 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.576 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -136.58 -31.39 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.911 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.986 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.1 mtp -119.95 46.41 1.95 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.674 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.728 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.32 125.47 35.53 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.597 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.8 28.55 58.84 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.884 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -71.22 148.88 46.82 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 112.043 -177.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.118 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -111.02 135.18 50.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.527 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.026 HG11 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.16 150.5 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' HA ' ' HB ' ' A' ' 6' ' ' ILE . 19.6 mtt180 -143.85 163.79 32.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.107 0.48 . . . . 0.0 112.015 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 6' ' ' ILE . 4.1 t -133.99 58.92 34.9 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.604 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 101' ' ' VAL . 85.5 Cg_endo -86.95 179.5 3.24 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.393 2.729 . . . . 0.0 112.988 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 104' ' ' PRO . 29.3 mt -151.48 164.37 20.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.335 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 103' ' ' LEU . 60.9 Cg_endo -74.04 95.53 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.579 2.186 . . . . 0.0 112.321 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.168 -179.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.456 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.727 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 51.6 Cg_exo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 121.991 0.746 . . . . 0.0 113.129 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.743 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -117.26 163.35 16.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.006 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -160.08 165.09 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.717 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.4 t -150.0 108.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.739 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -90.37 172.95 8.38 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.456 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 99' ' ' VAL . 4.1 mp -157.26 163.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 123.789 0.681 . . . . 0.0 110.286 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 6' ' ' ILE . 7.2 t0 -172.02 -166.13 0.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.514 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.87 -12.06 20.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.48 -179.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -89.95 7.73 35.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.0 111.132 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -170.9 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.226 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 81.32 18.76 68.22 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.185 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HA ' HG13 ' A' ' 6' ' ' ILE . 53.9 tt0 168.8 141.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.878 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.724 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 48.0 m-85 -146.39 59.15 1.22 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.912 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -46.81 142.02 3.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.063 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.108 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.8 p -166.89 -155.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.959 0.885 . . . . 0.0 111.966 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -158.78 160.88 36.8 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.435 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.66 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.1 -174.97 4.07 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.842 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 2.6 mt-30 -140.41 127.65 21.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.434 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 5.2 m-20 -34.87 112.64 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.362 0.601 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.92 -1.78 11.86 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.986 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 90' ' ' ILE . 5.2 mt-30 -121.43 146.94 46.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.679 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 6.2 p -95.02 -176.01 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.16 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 97' ' ' LEU . 2.4 mm? -85.91 11.15 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.656 ' O ' ' HE3' ' A' ' 24' ' ' MET . 0.0 OUTLIER -100.31 -27.41 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.548 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.613 ' HG2' ' HE2' ' A' ' 24' ' ' MET . 1.7 mt-10 -90.37 -40.81 11.86 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.899 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.9 -57.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 118.239 -1.385 . . . . 0.0 107.711 178.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.804 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.95 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.17 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.99 -30.93 4.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.782 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.6 mt-30 -78.9 -31.25 45.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.891 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.108 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -87.95 5.91 38.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.35 67.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.388 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.722 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 5.4 t -49.55 145.92 7.55 Favored Pre-proline 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 111.319 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.724 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 24.1 Cg_exo -29.11 -32.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 124.632 3.555 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 57.5 64.44 4.37 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.698 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.7 mm -89.72 39.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.024 0.44 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 5.7 m -130.37 -152.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.956 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 81.91 10.8 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.841 0.353 . . . . 0.0 111.164 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.05 -79.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 18.1 p -85.52 -27.71 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.43 77.69 0.2 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.245 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.45 33.88 88.43 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.676 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -111.33 -19.01 12.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.823 0.344 . . . . 0.0 110.775 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.8 m 53.19 45.29 28.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 39' ' ' CYS . 5.7 p -124.28 4.06 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 1.1 p -131.57 167.29 19.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.15 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.6 25.63 6.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.403 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.5 m -88.73 -14.07 38.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 36' ' ' VAL . 14.3 p -95.61 -10.02 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.023 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -33.75 100.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.488 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -110.08 -178.48 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.456 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 50' ' ' ILE . 5.8 mt-10 -142.43 115.18 8.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.661 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.065 HG22 ' OE1' ' A' ' 53' ' ' GLU . 5.0 mm -68.35 146.83 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.065 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.43 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.633 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -92.9 23.78 4.02 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 111.873 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.96 -30.29 6.75 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.432 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.127 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -110.02 5.75 22.47 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' A' ' 62' ' ' GLU . 38.4 t -64.41 -38.41 82.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.102 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.65 -5.67 57.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.974 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 93' ' ' SER . 5.6 mt -100.27 -37.74 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.752 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.885 ' CG1' HG11 ' A' ' 88' ' ' VAL . 21.3 t -87.81 -40.28 13.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.033 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 81.08 84.51 0.72 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.267 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' A' ' 57' ' ' VAL . 11.2 mt-10 -48.19 -177.37 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.274 0.559 . . . . 0.0 110.585 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . . . -76.26 145.9 39.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.495 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -55.87 178.97 0.11 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.05 178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 17.2 Cg_exo -67.7 2.62 2.35 Favored 'Trans proline' 0 C--N 1.328 -0.515 0 C-N-CA 123.609 2.873 . . . . 0.0 112.228 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -90.01 -54.92 3.82 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.826 0.346 . . . . 0.0 110.109 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' ALA . 5.7 tp10 -52.95 -45.8 67.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.755 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -65.64 -35.37 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.483 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.93 99.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.52 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.48 -38.5 84.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.516 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.58 -30.44 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.58 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -35.25 79.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.63 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -31.18 65.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -71.83 -48.97 42.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.82 11.83 3.86 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.67 111.94 65.27 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.26 178.7 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.74 2.294 . . . . 0.0 112.222 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -116.61 175.04 5.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.8 p -121.26 -159.9 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.679 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.02 129.92 36.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.941 0.4 . . . . 0.0 111.344 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 70.24 20.61 76.78 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.173 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -67.85 135.59 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -169.47 138.09 1.91 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.145 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.5 OUTLIER -57.83 115.64 2.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.474 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' SER . 0.8 OUTLIER -53.99 -40.62 67.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.868 -179.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 24' ' ' MET . 1.8 p -92.23 31.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 1.2 tt0 -122.45 -27.29 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.885 HG11 ' CG1' ' A' ' 60' ' ' VAL . 38.2 t -110.27 127.45 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.483 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 9.7 m-30 -108.95 137.96 46.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.63 0.728 . . . . 0.0 112.702 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.661 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.0 mm -45.23 161.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.324 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 178.11 170.05 0.49 Allowed Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.2 Cg_exo -65.49 45.93 0.17 Allowed 'Trans proline' 0 C--N 1.333 -0.241 0 C-N-CA 122.376 2.051 . . . . 0.0 110.999 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.15 -38.15 0.38 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.743 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 60' ' ' VAL . 13.3 mtp -112.16 43.55 1.57 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.628 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.727 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.36 124.25 34.77 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.266 -179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.85 27.52 60.48 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.22 153.25 41.69 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.572 0.701 . . . . 0.0 112.384 -177.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.127 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -114.5 136.21 51.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.25 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.884 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.77 145.29 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 6' ' ' ILE . 3.6 mtt180 -134.54 162.19 32.96 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.266 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ILE . 21.7 t -128.24 137.84 31.72 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 55.7 Cg_endo -70.27 -177.29 1.97 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.881 2.388 . . . . 0.0 112.543 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -76.74 151.21 82.35 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.548 ' HD2' HD23 ' A' ' 103' ' ' LEU . 74.5 Cg_endo -75.3 100.38 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.775 2.317 . . . . 0.0 112.45 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.244 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.442 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.714 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 122.096 0.79 . . . . 0.0 113.072 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -117.24 165.02 13.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.468 -1.697 . . . . 0.0 107.124 177.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.113 HG22 HD13 ' A' ' 97' ' ' LEU . 1.3 t -161.45 172.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 118.067 -1.453 . . . . 0.0 112.607 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 99' ' ' VAL . 15.6 t -155.92 110.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.779 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -93.69 176.77 6.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.164 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -151.34 160.92 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.578 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.8 t0 -170.66 166.84 8.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.385 0.612 . . . . 0.0 111.636 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.3 tt0 -81.98 -0.72 45.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.63 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -89.31 -36.48 15.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.108 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -137.4 -1.62 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.631 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 62.26 19.51 59.68 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.971 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.562 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 13.6 tt0 170.47 142.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.382 0.611 . . . . 0.0 111.089 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.766 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 40.5 m-85 -146.95 62.12 1.19 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.944 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.41 139.13 20.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.2 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.089 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.2 p -163.09 -156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.939 0.876 . . . . 0.0 112.095 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.957 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.3 m-20 -155.32 163.34 40.24 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.239 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -142.43 -171.74 3.47 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 19.6 mm-40 -141.58 136.08 30.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.481 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.585 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -43.4 106.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.43 -7.29 10.52 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.489 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 90' ' ' ILE . 17.1 mt-30 -103.82 140.93 36.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 24.9 p -89.71 167.97 12.48 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -80.68 6.99 11.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.688 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.677 ' N ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -101.73 -36.58 8.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 26' ' ' VAL . 29.2 tp10 -76.56 -38.72 54.54 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.716 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.718 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -49.7 -56.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.778 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -28.19 -74.99 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.573 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -29.96 3.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.676 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.3 mt-30 -78.44 -31.55 48.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.089 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.86 6.18 40.3 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.329 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.79 75.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.987 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 27' ' ' ALA . 5.1 t -48.66 157.33 0.75 Allowed Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 123.049 0.54 . . . . 0.0 110.413 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.766 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 10.6 Cg_exo -77.33 12.77 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.458 2.772 . . . . 0.0 113.827 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . 34.5 71.19 0.14 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.214 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.807 HG13 HG11 ' A' ' 101' ' ' VAL . 8.7 mm -70.3 55.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 48' ' ' CYS . 2.2 p 148.82 142.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.92 0.391 . . . . 0.0 111.184 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.91 48.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -60.62 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.6 p -94.33 -36.36 11.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 33.32 61.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.246 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.65 -12.99 35.63 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.108 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 10.6 t -88.01 -18.48 28.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.775 0.321 . . . . 0.0 111.018 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.0 t 56.43 61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.927 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 39' ' ' CYS . 4.4 m -137.91 7.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.301 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.452 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.5 OUTLIER -130.72 -179.0 5.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.95 17.42 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.14 15.26 10.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.74 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.705 ' HB3' HG21 ' A' ' 36' ' ' VAL . 29.5 p -105.21 40.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.726 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -80.43 57.13 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.046 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -55.97 177.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 100' ' ' ARG . 7.2 mt-10 -134.99 116.93 15.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.032 HG22 ' OE1' ' A' ' 53' ' ' GLU . 9.6 mm -70.28 147.28 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.032 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.32 178.15 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 117.306 -1.758 . . . . 0.0 108.511 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -92.2 24.27 3.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.742 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.81 -31.4 6.14 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.649 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.094 ' NE1' HD13 ' A' ' 98' ' ' ILE . 25.3 m95 -107.24 0.73 23.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 53' ' ' GLU . 46.3 t -63.29 -37.82 80.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.838 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -79.6 -6.83 57.88 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.806 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.2 mt -98.77 -39.1 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.969 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.027 HG22 ' HG2' ' A' ' 94' ' ' MET . 15.2 t -90.79 -83.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.614 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 18.22 50.7 0.01 OUTLIER Glycine 0 C--N 1.344 0.981 0 O-C-N 123.458 0.474 . . . . 0.0 112.972 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.4 mt-10 -89.99 -16.11 30.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.7 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -48.24 156.6 0.38 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.278 0.561 . . . . 0.0 111.059 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.43 178.37 1.91 Allowed Pre-proline 0 N--CA 1.433 -1.293 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -79.06 12.63 2.22 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 123.563 2.842 . . . . 0.0 110.705 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.87 -63.51 1.21 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.161 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.7 ' CD ' ' HB1' ' A' ' 63' ' ' ALA . 5.0 pt-20 -59.36 -26.14 64.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -72.27 -39.21 68.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.952 0.406 . . . . 0.0 110.288 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -81.36 -30.6 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.185 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.55 -22.23 63.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.065 179.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.693 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.5 tp -87.96 -44.24 11.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.408 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -36.24 37.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.806 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -24.44 60.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.381 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' HA ' ' A' ' 71' ' ' LEU . 34.9 p -50.7 -57.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.777 0.322 . . . . 0.0 111.077 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.11 -6.69 15.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.384 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' A' ' 49' ' ' ARG . 2.2 mt-10 -91.41 133.71 30.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.63 177.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.879 2.386 . . . . 0.0 112.13 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 77.9 mtp -151.57 -172.77 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.44 -164.92 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.17 139.94 30.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.513 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 80.43 -11.58 37.64 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.937 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 HG23 ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -53.91 145.82 15.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.682 0.277 . . . . 0.0 110.605 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' NE ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -161.09 175.79 12.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -86.99 125.38 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.857 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -60.64 -47.71 85.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.945 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.494 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.5 p -91.08 16.07 10.42 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.54 -19.11 8.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 110.926 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.927 HG13 ' HE1' ' A' ' 94' ' ' MET . 11.9 t -92.06 124.17 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.217 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 3.7 m-85 -127.85 156.47 42.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.742 0.782 . . . . 0.0 112.663 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.712 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.7 mm -72.88 155.66 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.959 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -176.88 167.67 1.32 Allowed Pre-proline 0 N--CA 1.444 -0.763 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.505 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.78 46.05 0.19 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 122.455 2.104 . . . . 0.0 111.145 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -143.16 -36.28 0.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.91 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 1.027 ' HG2' HG22 ' A' ' 60' ' ' VAL . 21.8 mtp -114.21 44.1 1.74 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.714 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.47 120.07 31.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.181 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.615 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 79.94 28.1 51.25 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.113 HD13 HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -76.04 147.3 38.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 111.301 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.094 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.2 mp -108.67 138.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.372 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -113.01 -178.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -166.1 136.19 3.38 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.473 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.807 HG11 HG13 ' A' ' 35' ' ' ILE . 74.0 t -99.75 133.07 22.02 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.808 0.337 . . . . 0.0 110.99 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.9 Cg_exo -48.97 -164.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 123.035 2.49 . . . . 0.0 113.131 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 141.5 35.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.197 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -32.47 113.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.438 2.759 . . . . 0.0 112.795 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.11 179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.452 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.793 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 122.065 0.777 . . . . 0.0 113.516 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.806 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.86 163.98 15.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.341 -1.754 . . . . 0.0 107.217 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.997 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -161.77 166.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 118.078 -1.449 . . . . 0.0 113.131 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.1 t -149.53 108.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.699 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 3.0 m-30 -91.6 173.56 7.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.407 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.919 HD12 ' O ' ' A' ' 99' ' ' VAL . 3.8 mp -155.21 162.05 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 123.566 0.541 . . . . 0.0 111.01 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.59 ' N ' HG22 ' A' ' 6' ' ' ILE . 15.6 t0 -172.0 -177.07 1.82 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.916 0.389 . . . . 0.0 111.304 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -1.01 57.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.552 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 34.9 mm-40 -89.6 -36.03 15.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.591 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 26.5 t -135.27 0.55 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.43 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 58.81 18.36 39.06 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.516 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.4 tt0 168.79 144.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.233 0.54 . . . . 0.0 110.59 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.77 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 50.5 m-85 -147.36 61.0 1.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.943 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.3 141.97 8.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.03 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.132 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.45 -155.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.92 0.867 . . . . 0.0 112.041 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.929 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -158.16 161.71 37.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.465 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.33 -176.39 4.6 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.787 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.467 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 32.3 mt-30 -137.87 127.87 25.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.624 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.622 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -36.49 110.14 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 110.392 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.71 -3.64 11.95 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 90' ' ' ILE . 11.5 mt-30 -114.4 155.3 26.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.862 0.363 . . . . 0.0 110.265 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 18.9 p -100.4 -175.68 2.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.245 0.545 . . . . 0.0 111.898 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -89.88 5.81 44.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.465 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.52 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 8.2 ptm -98.33 -31.8 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.516 ' N ' ' HG3' ' A' ' 24' ' ' MET . 0.6 OUTLIER -83.71 -39.67 19.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.545 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.655 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -50.96 -57.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 118.044 -1.462 . . . . 0.0 107.211 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.784 ' HA ' HG21 ' A' ' 32' ' ' VAL . . . -27.73 -73.22 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.577 -1.647 . . . . 0.0 112.412 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.8 -30.92 4.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.793 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 84.0 mt-30 -80.62 -29.49 36.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.282 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.132 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.58 5.39 43.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.645 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.21 5.34 85.2 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.391 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.886 HG12 ' HD2' ' A' ' 33' ' ' PRO . 6.7 t -53.37 161.13 1.52 Allowed Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.391 0.676 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.886 ' HD2' HG12 ' A' ' 32' ' ' VAL . 49.9 Cg_exo -62.44 64.79 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.81 2.34 . . . . 0.0 114.228 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 37.18 77.98 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.563 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 50' ' ' ILE . 34.6 mm -84.02 43.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.75 0.31 . . . . 0.0 110.823 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.56 171.25 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.276 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -141.05 177.58 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.228 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -92.51 -19.19 22.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 42' ' ' SER . 0.8 OUTLIER -92.23 -8.08 46.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.083 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 41.7 40.92 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.534 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.68 66.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.588 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.669 ' O ' HG23 ' A' ' 44' ' ' VAL . 13.4 t -87.69 14.29 8.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 111.172 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 t 46.33 59.71 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.793 HG12 ' O ' ' A' ' 44' ' ' VAL . 76.0 t -144.25 33.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -163.73 179.68 6.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.67 10.44 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -73.31 -1.81 19.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ILE . 7.5 p -96.62 22.23 8.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 5.6 tpt180 -53.33 81.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.166 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 35' ' ' ILE . 4.6 mm -94.99 151.03 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.177 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.582 ' CG ' HG23 ' A' ' 82' ' ' THR . 13.6 mt-10 -130.18 109.64 10.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 60' ' ' VAL . 13.4 mm -67.89 137.07 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.803 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -53.45 177.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.855 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.51 23.55 3.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.204 0.526 . . . . 0.0 111.855 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 56' ' ' TRP . . . -113.46 -27.46 7.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.43 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.121 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.2 m95 -112.06 6.64 19.37 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 53' ' ' GLU . 49.4 t -68.17 -36.42 75.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.806 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -80.99 -4.08 53.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.68 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 93' ' ' SER . 7.8 mt -104.29 -35.36 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.158 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.841 HG22 ' HG2' ' A' ' 94' ' ' MET . 78.9 t -90.93 -58.34 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.767 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 62' ' ' GLU . . . 53.42 62.9 5.56 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.76 ' CG ' HG21 ' A' ' 88' ' ' VAL . 29.7 mt-10 -48.17 -121.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.477 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.717 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -71.37 160.49 32.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.451 0.643 . . . . 0.0 112.265 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.0 p-10 -87.94 -174.25 0.47 Allowed Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.635 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 16.7 Cg_exo -66.5 2.77 1.73 Allowed 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.955 3.103 . . . . 0.0 113.375 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 4.3 m-20 -88.35 -36.47 16.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 110.225 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.892 ' HA ' HD23 ' A' ' 70' ' ' LEU . 3.3 tm-20 -86.43 -39.63 16.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.989 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.418 HD21 ' HE1' ' A' ' 78' ' ' MET . 1.8 t30 -68.5 -27.18 65.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.494 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 68.4 t0 -83.04 -33.09 26.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -74.55 -24.18 58.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.568 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -86.47 -38.16 17.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.653 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -63.68 -29.86 71.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.779 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -52.23 -21.27 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' LEU . 31.5 p -70.78 -40.6 72.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.71 21.87 6.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.426 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -114.7 109.57 47.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.922 0.391 . . . . 0.0 110.86 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -52.76 159.61 4.79 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.854 2.369 . . . . 0.0 112.637 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HE1' HD21 ' A' ' 68' ' ' ASN . 3.1 mtm -131.94 -173.2 3.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.102 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.432 ' C ' ' HG1' ' A' ' 82' ' ' THR . 1.0 OUTLIER -129.96 -175.66 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.97 124.56 28.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.029 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.71 -2.67 80.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.572 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.582 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -77.88 113.58 15.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.671 0.272 . . . . 0.0 111.01 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HD2' ' HB3' ' A' ' 63' ' ' ALA . 21.5 mtm-85 -170.21 149.31 3.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.611 HD21 ' HG3' ' A' ' 67' ' ' GLU . 2.4 pp -61.1 144.88 52.7 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 50' ' ' ILE . 32.1 m -92.31 -30.41 15.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 84' ' ' LEU . 29.7 p -47.17 -21.48 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.82 10.16 19.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.76 HG21 ' CG ' ' A' ' 62' ' ' GLU . 74.1 t -118.17 109.2 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.511 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 5.1 m-30 -109.93 144.35 38.57 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' CD ' ' A' ' 1' ' ' PRO . 2.3 mm -55.15 158.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 113.844 -1.525 . . . . 0.0 112.666 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -170.19 163.34 6.26 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.04 33.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.434 2.089 . . . . 0.0 112.565 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.795 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -127.15 -30.56 2.66 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.505 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.841 ' HG2' HG22 ' A' ' 60' ' ' VAL . 9.1 mtp -117.02 46.67 1.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.407 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.793 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -90.55 126.07 35.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 76.42 27.96 60.6 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.888 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.59 157.83 34.75 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 121.549 0.69 . . . . 0.0 111.727 -178.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.121 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.3 mp -113.55 136.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.124 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.919 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -125.99 153.3 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 51' ' ' GLU . 70.3 mtt-85 -132.57 167.0 20.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.444 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 6' ' ' ILE . 71.8 t -122.54 118.14 28.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.221 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 49' ' ' ARG . 77.2 Cg_endo -75.08 -178.99 4.57 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.867 2.378 . . . . 0.0 112.165 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.582 HD23 ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -178.74 156.17 0.91 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.582 ' HD2' HD23 ' A' ' 103' ' ' LEU . 16.9 Cg_exo -66.99 66.06 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.816 2.344 . . . . 0.0 112.213 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.987 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.509 ' S2 ' ' CB ' ' A' ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.709 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.4 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 CA-C-O 121.966 0.736 . . . . 0.0 113.181 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.16 158.72 22.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.365 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.045 HG12 HG12 ' A' ' 15' ' ' VAL . 1.4 t -155.15 170.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 118.307 -1.357 . . . . 0.0 112.415 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 99' ' ' VAL . 17.5 t -153.39 108.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.87 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.918 ' O ' HD13 ' A' ' 6' ' ' ILE . 2.9 m-30 -94.47 174.68 7.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.046 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.6 mm -152.29 162.55 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.942 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.723 ' OD1' HG21 ' A' ' 101' ' ' VAL . 4.1 t70 -171.15 167.64 7.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.382 0.611 . . . . 0.0 111.564 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.4 tp10 -82.0 -5.4 58.31 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.924 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -36.73 15.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.4 t -128.22 -7.87 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.274 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 62.8 17.97 58.79 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 19.2 tt0 168.16 144.77 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.275 0.56 . . . . 0.0 111.057 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 43.2 m-85 -148.76 59.94 1.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.068 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -51.1 134.23 26.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.265 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.073 HG21 ' OD1' ' A' ' 30' ' ' ASN . 3.2 p -157.46 -158.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.761 0.791 . . . . 0.0 112.138 -178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.92 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.4 m-20 -153.12 159.18 42.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.675 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.693 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -138.38 -173.06 3.43 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.863 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' NE2' ' OE1' ' A' ' 21' ' ' GLN . 39.1 mt-30 -138.75 134.08 33.05 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.06 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.679 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.0 m-20 -37.58 101.68 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.233 0.539 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' ILE . . . 121.35 -3.11 11.32 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.345 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' OE1' ' NE2' ' A' ' 18' ' ' GLN . 15.9 mt-30 -103.05 140.45 37.29 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.916 0.389 . . . . 0.0 110.861 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.539 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -92.94 171.73 8.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.598 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.054 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -75.33 -0.64 20.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.987 0.422 . . . . 0.0 110.119 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -91.68 -28.65 17.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.754 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.55 -41.29 12.79 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -53.34 -58.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.733 177.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.755 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.79 -71.07 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.407 -1.724 . . . . 0.0 112.077 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.02 -33.78 11.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.151 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' VAL . 30.1 mt-30 -74.51 -33.21 62.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.187 0.518 . . . . 0.0 109.997 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.073 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.98 7.14 36.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.898 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.03 20.92 71.27 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.19 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.704 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 21.2 t -73.45 138.8 77.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.694 ' HD3' ' CE2' ' A' ' 13' ' ' TYR . 56.8 Cg_endo -66.39 -154.4 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.04 2.493 . . . . 0.0 109.867 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.59 19.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.054 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' VAL . 26.6 mt -51.39 -55.7 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.523 0.661 . . . . 0.0 110.235 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 35' ' ' ILE . 1.5 t 29.72 89.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.767 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' HB2' ' CE ' ' A' ' 24' ' ' MET . . . -108.47 82.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.835 ' HG3' HG21 ' A' ' 47' ' ' THR . 22.2 mm-40 -78.17 -48.06 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.685 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 42' ' ' SER . 17.7 p -103.05 -25.69 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.849 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 35.9 77.4 0.05 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.593 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.59 -16.44 61.17 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -78.43 -20.29 51.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.57 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 62.8 m 44.36 51.65 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 42' ' ' SER . 21.6 t -138.62 40.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.352 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S2 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -155.23 173.9 15.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.938 0.399 . . . . 0.0 111.376 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.34 47.88 2.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.235 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.835 HG21 ' HG3' ' A' ' 38' ' ' GLU . 43.9 p -110.82 5.74 20.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.3 p -109.77 52.33 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.819 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.655 ' O ' HD13 ' A' ' 50' ' ' ILE . 10.7 tpt180 -71.69 95.19 1.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.226 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.676 HG21 HD21 ' A' ' 23' ' ' LEU . 6.3 mm -124.7 172.48 12.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.641 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.2 mt-10 -139.49 120.69 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 8.0 mm -68.83 146.93 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.54 159.92 2.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.786 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 30.4 m-20 -76.04 20.86 0.18 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 59' ' ' ILE . . . -113.48 -25.83 8.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.113 0.482 . . . . 0.0 110.486 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 39.4 m95 -107.43 -3.22 19.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 HG21 ' CA ' ' A' ' 81' ' ' GLY . 37.5 t -61.09 -40.29 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.284 -0.967 . . . . 0.0 109.317 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -79.79 -7.06 58.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.933 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.7 mt -97.18 -38.97 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.822 0.82 . . . . 0.0 109.139 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.98 HG22 ' HG2' ' A' ' 94' ' ' MET . 41.4 t -90.91 -80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.093 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.52 58.34 0.01 OUTLIER Glycine 0 C--N 1.339 0.729 0 O-C-N 123.546 0.529 . . . . 0.0 113.607 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 26.1 mt-10 -86.72 -16.39 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.643 ' HB2' ' NE ' ' A' ' 83' ' ' ARG . . . -59.66 155.25 16.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.687 0.756 . . . . 0.0 112.372 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.586 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -90.97 171.98 7.4 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.636 177.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 22.6 Cg_endo -61.63 3.15 0.41 Allowed 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 123.316 2.677 . . . . 0.0 112.78 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' LEU . 2.0 m-20 -91.17 -56.28 3.22 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.876 0.369 . . . . 0.0 110.327 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 3.0 tm-20 -46.96 -42.26 17.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 109.884 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -70.6 -33.61 71.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.485 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -80.1 -34.69 37.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 66' ' ' ASP . 7.9 tt -61.05 -38.99 88.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' NH1' ' A' ' 49' ' ' ARG . 3.7 mp -81.9 -40.16 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.044 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -26.24 54.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.01 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -77.78 -15.22 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -38.92 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.12 29.36 37.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.578 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -97.94 157.73 34.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.34 137.42 31.18 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.8 mtp -123.83 163.23 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.6 p -142.46 -171.56 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.519 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.67 124.4 34.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' CA ' HG21 ' A' ' 57' ' ' VAL . . . 87.54 5.53 78.63 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.517 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.448 HG23 ' OE2' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -63.97 127.82 33.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.357 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -169.74 148.78 3.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 13.5 mt -42.92 151.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -92.33 -71.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.562 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.576 ' O ' ' CZ ' ' A' ' 89' ' ' PHE . 1.7 p -59.56 -18.98 45.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.952 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 66.0 tp60 -76.92 -11.94 59.88 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.603 HG23 ' NH1' ' A' ' 83' ' ' ARG . 77.4 t -100.76 161.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 120.496 0.189 . . . . 0.0 110.851 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.585 ' N ' HG12 ' A' ' 88' ' ' VAL . 43.5 m-85 -154.47 139.62 17.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.3 mm -59.12 160.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.56 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.1 168.15 0.85 Allowed Pre-proline 0 N--CA 1.445 -0.71 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.529 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.8 Cg_exo -65.35 45.11 0.16 Allowed 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 122.441 2.094 . . . . 0.0 111.514 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -142.61 -36.58 0.39 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.636 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.98 ' HG2' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.99 42.91 1.53 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.536 -179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -89.13 124.25 34.15 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.602 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 83.62 35.79 15.7 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 -176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.893 HD12 ' CE3' ' A' ' 56' ' ' TRP . 2.2 tp -65.91 136.07 55.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.049 -1.075 . . . . 0.0 113.077 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 0.4 OUTLIER -111.91 112.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.023 178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.054 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -100.09 177.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.859 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 24.5 mtp180 -167.14 142.54 4.11 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.529 0.518 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 6' ' ' ILE . 90.9 t -97.81 138.26 21.01 Favored Pre-proline 0 CA--C 1.528 0.117 0 CA-C-O 120.644 0.259 . . . . 0.0 110.953 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 50' ' ' ILE . 16.6 Cg_exo -65.92 -162.02 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.423 0 C-N-CA 122.778 2.319 . . . . 0.0 112.797 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.7 165.42 53.26 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.986 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . 26.4 Cg_exo -62.53 -177.84 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.819 2.346 . . . . 0.0 112.236 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' PRO . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.053 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.459 ' S2 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 60.1 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.988 0.745 . . . . 0.0 113.445 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.661 ' O ' HG23 ' A' ' 3' ' ' VAL . 1.1 tpt180 -114.86 157.27 23.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.373 -1.739 . . . . 0.0 106.972 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG12 ' CG1' ' A' ' 15' ' ' VAL . 1.2 t -157.2 165.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.679 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 11.4 t -152.73 111.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.482 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.84 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -89.34 177.98 6.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.884 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 5' ' ' PHE . 20.2 mm -152.79 159.42 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.398 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 6' ' ' ILE . 9.5 t0 -171.52 -170.48 0.81 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.0 tt0 -106.85 0.85 24.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.054 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.61 -38.81 13.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 110.299 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.9 t -131.23 4.08 4.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.551 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 57.17 18.12 26.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.572 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 67.3 tt0 168.57 145.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.212 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.752 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 38.4 m-85 -145.96 61.9 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.029 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.01 145.52 10.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.688 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.118 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -169.41 -153.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.956 0.884 . . . . 0.0 112.176 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.93 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.6 OUTLIER -160.18 164.26 33.0 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.191 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.17 -175.14 4.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.786 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.453 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 10.4 mt-30 -138.86 126.37 21.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.132 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HA ' HG22 ' A' ' 90' ' ' ILE . 9.0 m-20 -37.0 113.03 0.22 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.381 0.61 . . . . 0.0 110.25 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.0 -3.48 11.58 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.686 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 8.1 mt-30 -117.35 153.28 33.29 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.295 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 91.6 p -98.97 -174.21 2.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 111.557 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.647 HD11 HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -92.27 6.97 44.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.896 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -98.48 -27.62 13.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -89.42 -39.21 13.54 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.678 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.73 -57.66 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.275 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.84 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.68 -75.31 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.768 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.61 -29.58 3.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.705 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.6 mt-30 -79.45 -31.48 42.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.047 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.118 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.39 6.63 36.49 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.453 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.38 -7.16 69.25 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.038 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.969 HG12 ' HD2' ' A' ' 33' ' ' PRO . 2.8 t -49.85 161.47 0.54 Allowed Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 123.225 0.61 . . . . 0.0 110.024 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.969 ' HD2' HG12 ' A' ' 32' ' ' VAL . 27.2 Cg_exo -66.7 -3.22 8.89 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.284 2.656 . . . . 0.0 112.198 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 29.71 66.36 0.12 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.219 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.637 HG22 HG12 ' A' ' 36' ' ' VAL . 2.9 mp 3.69 -71.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 124.279 0.635 . . . . 0.0 112.477 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 HG22 ' A' ' 35' ' ' ILE . 2.1 p 161.67 -46.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB2' ' SD ' ' A' ' 24' ' ' MET . . . 53.34 92.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -87.56 -37.09 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.237 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.525 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 17.9 p -63.67 -12.71 36.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.28 0.61 23.15 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.529 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.94 37.67 1.97 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.388 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -129.23 17.36 6.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 110.839 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t 55.56 65.2 1.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.683 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 39' ' ' CYS . 21.3 t -127.6 -1.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.225 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.1 p -135.5 178.99 6.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.05 20.48 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' ILE . 90.2 m -88.21 -26.94 22.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' ILE . 30.4 p -64.62 -10.51 27.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.8 ttp180 -28.94 88.68 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.692 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.604 HG21 ' CB ' ' A' ' 85' ' ' SER . 7.0 tt -96.11 171.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.503 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.806 ' CG ' HG23 ' A' ' 82' ' ' THR . 40.1 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.862 0.363 . . . . 0.0 111.827 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 12.0 mm -69.29 141.5 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -54.76 154.21 5.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 117.296 -1.762 . . . . 0.0 107.542 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.24 20.38 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.657 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -114.33 -27.08 7.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.302 0.572 . . . . 0.0 110.258 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.112 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.9 m95 -105.04 2.01 29.12 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.85 -36.19 76.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.585 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -4.61 57.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.814 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 56' ' ' TRP . 6.8 mt -102.09 -39.32 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.614 178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 ' HG2' ' A' ' 94' ' ' MET . 13.8 t -92.43 -78.46 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.312 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 24.01 42.75 0.01 OUTLIER Glycine 0 C--N 1.338 0.639 0 O-C-N 123.383 0.427 . . . . 0.0 113.087 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.6 mt-10 -76.44 -22.51 54.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 111.549 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.773 ' HB1' ' HG2' ' A' ' 67' ' ' GLU . . . -49.75 156.42 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.24 0.543 . . . . 0.0 111.343 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.618 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 49.0 p30 -90.29 177.53 2.32 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.618 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 2.7 Cg_exo -75.27 12.98 1.16 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 123.534 2.823 . . . . 0.0 111.792 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 69' ' ' ASP . 29.4 m-20 -91.62 -64.98 1.05 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.023 0.439 . . . . 0.0 110.649 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.773 ' HG2' ' HB1' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -45.5 -35.22 3.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.571 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 68' ' ' ASN . 1.9 t-20 -78.22 -30.22 48.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.768 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' ASP . 10.4 t70 -85.21 -22.69 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.809 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -78.8 -40.45 33.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.913 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.5 mm? -80.28 -20.16 45.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -79.52 -26.51 41.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.886 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 t -85.6 -24.35 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.017 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 70' ' ' LEU . 43.5 p -63.83 -52.59 59.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.088 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.19 7.31 4.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.75 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -104.93 135.66 19.27 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HG2' ' A' ' 78' ' ' MET . 73.8 Cg_endo -75.66 165.59 30.03 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.796 2.331 . . . . 0.0 112.475 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 77' ' ' PRO . 1.6 mtm -157.65 177.44 11.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 80' ' ' ALA . 32.0 p -141.84 150.6 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 79' ' ' THR . . . -37.7 107.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.22 -29.98 5.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.586 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.24 98.9 3.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.706 0.289 . . . . 0.0 111.436 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' NE ' ' HB2' ' A' ' 63' ' ' ALA . 16.6 ptt-85 -170.35 153.45 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.035 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -56.54 114.91 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.255 179.44 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.604 ' CB ' HG21 ' A' ' 50' ' ' ILE . 30.3 t -90.15 -8.21 51.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 19.9 p -55.4 -17.21 4.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.878 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.63 1.67 32.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.08 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' SER . 25.1 t -105.12 118.85 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.1 m-30 -110.29 142.38 41.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.863 0.84 . . . . 0.0 113.069 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.668 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.6 mm -51.34 161.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.6 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -175.94 168.46 1.5 Allowed Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 23.0 Cg_exo -65.65 44.08 0.16 Allowed 'Trans proline' 0 C--N 1.332 -0.294 0 C-N-CA 122.401 2.067 . . . . 0.0 111.523 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -140.36 -36.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.638 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.997 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.3 mtp -109.69 42.11 1.55 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.497 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.765 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.92 128.32 36.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.421 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.621 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.42 26.76 67.12 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.927 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 157.0 38.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.61 0.719 . . . . 0.0 112.49 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.112 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -119.38 134.44 62.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.475 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.57 157.73 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.556 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -143.19 162.33 35.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 111.193 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 6' ' ' ILE . 30.9 t -115.25 139.33 24.34 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.811 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 101' ' ' VAL . 37.7 Cg_endo -65.43 -175.19 0.4 Allowed 'Trans proline' 0 CA--C 1.521 -0.134 0 C-N-CA 122.623 2.215 . . . . 0.0 112.402 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 82.7 mt -84.97 131.28 49.36 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.106 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 24.7 Cg_exo -62.57 -177.64 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.63 2.22 . . . . 0.0 112.121 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.027 -179.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 52.3 Cg_exo . . . . . 0 N--CA 1.492 1.432 0 CA-C-O 122.099 0.791 . . . . 0.0 113.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.2 ttm105 -117.0 164.34 14.86 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.334 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.046 HG22 HD13 ' A' ' 97' ' ' LEU . 1.5 t -161.68 165.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 C-N-CA 118.028 -1.469 . . . . 0.0 112.833 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' ILE . 23.4 t -151.88 110.9 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.746 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.807 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.8 m-30 -92.49 171.44 9.03 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.3 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.821 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.1 mm -149.23 162.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.709 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.6 t70 -170.97 -173.9 1.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.943 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 2.8 tt0 -99.17 -6.15 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.364 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -89.54 -32.42 17.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.759 0.314 . . . . 0.0 110.939 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -132.24 1.29 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 53.51 18.13 7.13 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.812 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 56.7 tt0 168.09 145.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.267 0.556 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.702 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 46.6 m-85 -146.37 59.58 1.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.017 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -49.32 142.86 6.93 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.671 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.119 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.7 p -166.96 -154.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-O 121.85 0.833 . . . . 0.0 111.808 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.886 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -160.34 163.51 33.2 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.5 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.622 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -143.17 -175.38 4.51 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.559 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HA ' ' CD ' ' A' ' 1' ' ' PRO . 20.0 mt-30 -140.4 127.56 20.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.146 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.595 ' HA ' HG22 ' A' ' 90' ' ' ILE . 10.9 m-20 -35.61 112.02 0.15 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.471 0.653 . . . . 0.0 110.632 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 121.5 4.01 10.04 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.871 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 6.2 mt-30 -125.06 146.54 49.4 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.888 0.375 . . . . 0.0 110.527 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 85' ' ' SER . 2.8 p -95.07 -175.64 3.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.257 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -88.84 16.49 6.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.376 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.748 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -104.6 -28.18 11.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.254 178.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HG2' ' SD ' ' A' ' 24' ' ' MET . 35.8 mt-10 -90.36 -41.73 11.34 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.381 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -50.31 -58.05 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 117.987 -1.485 . . . . 0.0 107.72 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.807 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.17 -75.62 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.283 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.25 -28.17 2.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.943 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mm-40 -80.94 -31.65 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.119 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.5 5.79 40.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.781 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.96 11.14 84.94 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.164 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.738 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 10.0 t -65.4 143.35 98.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-O 121.421 0.629 . . . . 0.0 112.075 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.702 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 21.7 Cg_exo -31.13 -31.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.379 3.386 . . . . 0.0 112.782 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 62.82 50.98 59.12 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.787 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 35' ' ' ILE . 7.0 mt -87.65 53.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.831 0.348 . . . . 0.0 110.693 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -124.45 28.03 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.452 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . . . 55.51 -178.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.463 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -95.45 -20.54 18.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.861 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.928 ' HB2' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -56.49 -28.85 60.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.417 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 35.35 63.22 0.57 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.053 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.82 -10.5 68.36 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.402 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -61.08 -12.81 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.872 0.336 . . . . 0.0 111.009 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 0.6 OUTLIER 60.95 15.43 6.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.793 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.928 HG22 ' HB2' ' A' ' 39' ' ' CYS . 3.0 m -95.17 -0.29 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -133.11 -175.16 3.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.997 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.67 22.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.61 12.11 28.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HB3' HG22 ' A' ' 36' ' ' VAL . 2.4 p -92.72 47.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HD3' HD21 ' A' ' 71' ' ' LEU . 13.4 mmm-85 -74.54 90.12 2.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.977 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.86 HD12 ' CB ' ' A' ' 85' ' ' SER . 4.9 mt -115.93 150.63 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.342 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 82' ' ' THR . 6.5 mt-10 -124.8 121.45 34.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.881 0.372 . . . . 0.0 111.917 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.642 HD12 HG21 ' A' ' 60' ' ' VAL . 6.2 mm -68.05 145.74 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.25 160.85 1.49 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.002 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 7.1 m-20 -77.45 20.25 0.31 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -112.98 -24.6 9.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.552 . . . . 0.0 110.13 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.123 ' NE1' HD13 ' A' ' 98' ' ' ILE . 30.0 m95 -110.24 1.26 18.52 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 42.3 t -63.96 -37.47 79.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.057 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -79.32 -6.12 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.869 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 93' ' ' SER . 5.5 mt -102.9 -38.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.416 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.975 HG22 ' HG2' ' A' ' 94' ' ' MET . 43.6 t -91.95 -89.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.836 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 19.0 48.03 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.608 0.568 . . . . 0.0 113.18 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' HB2' HG22 ' A' ' 88' ' ' VAL . 2.9 mm-40 -90.62 -19.04 24.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -48.63 145.54 3.57 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.056 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.607 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 6.6 p30 -79.4 175.96 4.22 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.607 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 8.8 Cg_exo -72.54 11.09 0.86 Allowed 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 123.609 2.873 . . . . 0.0 111.682 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.1 -51.64 5.09 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.6 mm-40 -64.86 -28.29 69.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.722 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -82.88 -30.37 28.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.997 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -82.65 -48.42 10.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.786 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.642 HD22 ' O ' ' A' ' 70' ' ' LEU . 1.9 tm? -51.24 -35.41 36.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.564 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -80.3 -46.48 16.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.474 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -28.59 35.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.647 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -21.2 55.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.3 p -81.05 -35.42 31.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.31 35.95 13.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.671 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -94.82 157.86 36.11 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.13 156.29 30.32 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.789 2.326 . . . . 0.0 112.337 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.09 165.5 25.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -144.71 -162.13 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.018 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.38 126.98 36.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 88.26 -16.9 50.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.883 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -59.31 127.58 32.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.755 0.312 . . . . 0.0 110.419 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 83' ' ' ARG . 3.1 ttp-105 -167.08 173.9 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -75.02 106.87 6.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.247 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.86 ' CB ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -68.39 -31.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.676 -179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 2.3 p -86.29 30.81 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.56 ' CG ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 tp60 -131.52 -21.8 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 62' ' ' GLU . 21.6 t -107.48 129.02 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.832 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.5 m-30 -110.53 132.7 53.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.597 0.713 . . . . 0.0 112.195 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.659 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.8 mm -37.23 161.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.257 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -179.72 169.19 0.72 Allowed Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.506 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.0 Cg_exo -65.38 45.31 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.45 2.1 . . . . 0.0 111.136 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.671 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -140.97 -36.64 0.45 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.786 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.975 ' HG2' HG22 ' A' ' 60' ' ' VAL . 24.7 mtp -115.32 45.21 1.69 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.621 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.712 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER -90.38 127.33 36.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.605 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 73.13 25.82 72.41 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.069 HD11 HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.49 153.27 35.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.787 0.803 . . . . 0.0 111.472 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.123 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -112.29 136.48 48.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.264 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -120.25 151.51 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.1 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' NE ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -146.72 157.98 43.81 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 6' ' ' ILE . 12.2 t -126.42 94.19 41.28 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.009 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 101' ' ' VAL . 61.7 Cg_exo -43.7 -173.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.306 2.67 . . . . 0.0 114.282 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -158.81 160.1 29.33 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.883 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.725 ' N ' HD22 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -43.85 88.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.222 2.615 . . . . 0.0 112.225 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' LEU . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.175 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.455 ' S2 ' ' O ' ' A' ' 36' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 35.8 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 121.774 0.656 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -116.45 158.02 24.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.99 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 15' ' ' VAL . 1.1 t -153.89 171.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.317 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 99' ' ' VAL . 12.7 t -154.87 109.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.323 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 m-30 -92.04 174.25 7.42 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.212 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.949 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -151.67 156.69 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.743 ' OD2' HG21 ' A' ' 101' ' ' VAL . 2.1 t0 -171.2 165.89 7.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.898 0.38 . . . . 0.0 111.041 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 -7.46 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.081 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HB2' ' OH ' ' A' ' 13' ' ' TYR . 1.2 mm-40 -89.42 -32.07 17.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -130.31 -3.21 4.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.061 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . 54.83 17.71 9.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.529 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 11.3 tt0 167.57 144.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.141 0.496 . . . . 0.0 110.742 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.696 ' CE2' ' CD ' ' A' ' 33' ' ' PRO . 54.9 m-85 -147.2 62.51 1.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -52.68 132.8 36.54 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.012 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.075 HG12 HG12 ' A' ' 3' ' ' VAL . 4.1 p -156.08 -156.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.831 0.824 . . . . 0.0 111.707 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.932 ' H ' HG22 ' A' ' 15' ' ' VAL . 2.2 m-20 -156.86 162.74 39.68 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.342 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -140.86 -178.22 5.45 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.844 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 21' ' ' GLN . 50.6 mt-30 -134.12 125.64 28.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.494 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.627 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -37.83 113.96 0.31 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 110.414 -178.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.87 -1.86 11.93 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.303 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 18' ' ' GLN . 10.0 mt-30 -117.77 152.28 35.61 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 110.256 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 87.5 p -99.09 -176.02 3.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 0.0 111.246 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -88.91 6.38 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.921 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -97.3 -33.47 11.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.1 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 26' ' ' VAL . 4.3 mt-10 -83.51 -39.06 20.95 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.07 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -49.95 -56.86 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.483 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.81 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -28.04 -75.18 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.571 -1.65 . . . . 0.0 112.471 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -29.96 3.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.723 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 26' ' ' VAL . 6.2 mt-30 -78.34 -31.66 48.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.64 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.064 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.71 5.31 43.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.277 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.28 -2.2 72.27 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.356 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 27' ' ' ALA . 8.6 t -50.4 145.75 10.02 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.181 0.593 . . . . 0.0 111.737 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.696 ' CD ' ' CE2' ' A' ' 13' ' ' TYR . 18.1 Cg_exo -31.51 -30.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.095 3.197 . . . . 0.0 112.367 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . 55.61 26.18 45.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.812 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 35' ' ' ILE . 44.6 mm -72.37 57.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.897 0.38 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -156.23 -167.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.064 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' VAL . . . 68.72 64.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.093 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -89.16 -17.84 28.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.604 ' HB2' HG12 ' A' ' 44' ' ' VAL . 17.7 p -120.2 -30.06 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.43 59.72 0.92 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.468 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 39.73 52.19 3.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.615 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.3 -1.87 11.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.701 0.286 . . . . 0.0 110.969 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 59.66 52.02 5.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 39' ' ' CYS . 5.1 p -132.5 0.02 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.311 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.459 ' O ' ' S1 ' ' A' ' 106' ' ' FES . 0.7 OUTLIER -137.56 171.16 14.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.935 0.397 . . . . 0.0 111.279 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.95 8.85 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.935 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.2 m -68.66 -12.94 62.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.85 ' HA ' HG12 ' A' ' 36' ' ' VAL . 10.7 p -87.06 44.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' NH1' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -63.81 78.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB3' ' A' ' 85' ' ' SER . 3.3 mt -97.35 166.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.032 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' N ' HG22 ' A' ' 50' ' ' ILE . 11.5 mt-10 -141.92 119.73 11.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.045 HG22 ' OE1' ' A' ' 53' ' ' GLU . 7.7 mm -69.27 148.87 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.045 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -54.91 179.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.644 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -93.52 23.33 4.67 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.726 -0.609 . . . . 0.0 111.85 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.655 ' H ' ' HG2' ' A' ' 53' ' ' GLU . . . -114.51 -30.59 6.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.651 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.129 ' NE1' HD13 ' A' ' 98' ' ' ILE . 22.6 m95 -108.23 3.49 23.69 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.757 HG13 ' HA2' ' A' ' 81' ' ' GLY . 44.6 t -64.6 -38.45 82.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 118.533 -1.267 . . . . 0.0 108.685 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.29 -6.28 54.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.789 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 56' ' ' TRP . 5.3 mt -99.41 -39.97 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.495 0 CA-C-O 122.082 0.944 . . . . 0.0 108.854 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.866 HG13 ' HE1' ' A' ' 94' ' ' MET . 64.3 t -91.14 -84.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 113.646 -1.615 . . . . 0.0 110.157 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 83' ' ' ARG . . . 18.15 50.51 0.01 OUTLIER Glycine 0 C--N 1.34 0.754 0 O-C-N 123.506 0.504 . . . . 0.0 113.701 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' CE ' ' A' ' 94' ' ' MET . 4.0 mt-10 -78.01 -18.5 55.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.774 0.321 . . . . 0.0 111.784 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HB2' ' HE ' ' A' ' 83' ' ' ARG . . . -49.35 155.02 0.77 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.317 0.58 . . . . 0.0 112.069 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.564 ' CB ' ' HD2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -90.83 170.5 9.81 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 64' ' ' ASN . 18.0 Cg_endo -59.5 -0.27 0.7 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.181 2.587 . . . . 0.0 112.705 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 69' ' ' ASP . 1.9 m-20 -91.71 -63.6 1.23 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.392 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.913 ' HA ' HD23 ' A' ' 70' ' ' LEU . 9.5 mt-10 -40.39 -45.34 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.32 -30.94 63.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.74 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 66' ' ' ASP . 23.9 t0 -76.85 -37.81 54.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -60.6 -35.72 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.482 HD22 ' NH1' ' A' ' 49' ' ' ARG . 7.8 mt -83.56 -35.12 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.964 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -27.23 68.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.56 -34.4 75.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.971 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.1 p -59.04 -35.57 73.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.797 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.06 17.04 63.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.64 162.97 32.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.999 0.428 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.5 122.33 9.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.857 2.372 . . . . 0.0 112.348 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 71' ' ' LEU . 60.7 mtp -134.3 154.28 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.4 p -118.37 -172.5 2.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.712 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.51 ' O ' HG21 ' A' ' 57' ' ' VAL . . . -82.89 115.75 21.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.757 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . 120.39 -29.78 5.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.716 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.526 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.77 103.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.702 0.287 . . . . 0.0 110.466 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.736 ' NH2' HG21 ' A' ' 88' ' ' VAL . 12.6 mtm-85 -156.36 168.14 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.088 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD23 ' S1 ' ' A' ' 106' ' ' FES . 6.4 mp -60.88 75.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.508 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.568 ' HB3' HD12 ' A' ' 50' ' ' ILE . 12.8 t -41.74 -41.97 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.6 p -59.24 -12.93 6.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.292 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -101.25 -1.25 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG11 HG13 ' A' ' 60' ' ' VAL . 50.6 t -108.59 121.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.719 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 7.9 m-30 -110.82 139.79 45.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.745 0.783 . . . . 0.0 112.586 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.698 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 1.7 mm -49.95 142.83 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.682 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 93' ' ' SER . 1.6 p30 -157.06 146.76 15.4 Favored Pre-proline 0 N--CA 1.426 -1.638 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' ASP . 19.6 Cg_exo -34.56 -28.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.476 0 C-N-CA 122.146 1.897 . . . . 0.0 110.539 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -79.15 26.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 176.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.938 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.6 mtt -170.46 42.48 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 4.2 m-20 -94.86 125.32 39.44 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.731 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.633 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 82.33 34.4 23.27 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.938 HD11 ' HG2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -65.94 152.75 43.84 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.129 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -123.34 118.51 54.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.615 178.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -100.93 -175.47 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.685 ' H ' HG12 ' A' ' 99' ' ' VAL . 10.0 mtt180 -165.76 149.96 8.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.752 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 6' ' ' ILE . 41.2 t -114.24 109.32 49.16 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.5 Cg_endo -85.13 48.44 2.29 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 123.405 2.737 . . . . 0.0 113.485 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -83.77 175.72 4.45 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.448 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.464 ' HD2' ' HG ' ' A' ' 103' ' ' LEU . 97.1 Cg_endo -91.87 154.06 3.36 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.893 2.396 . . . . 0.0 112.267 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.892 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . 0.546 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.7 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 50.1 Cg_exo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 121.847 0.686 . . . . 0.0 113.154 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -112.96 160.87 17.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 113.578 -1.646 . . . . 0.0 107.505 177.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 15' ' ' VAL . 1.2 t -158.81 171.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.716 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 99' ' ' VAL . 10.5 t -153.91 110.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 112.321 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.886 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.0 m-30 -94.84 177.28 5.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.786 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 5' ' ' PHE . 1.2 mm -153.33 167.57 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.981 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 18.5 t70 -170.72 167.25 7.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.425 0.631 . . . . 0.0 110.85 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -82.02 -11.53 58.78 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.201 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 11.4 mm-40 -90.02 -33.65 16.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.768 0.318 . . . . 0.0 111.244 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -121.38 -25.49 5.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.061 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 76.45 18.1 79.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.921 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 34.4 tt0 168.37 139.48 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.255 0.55 . . . . 0.0 111.386 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.762 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 27.8 m-85 -144.23 59.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.813 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -48.84 139.51 9.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.2 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.074 HG21 ' OD1' ' A' ' 30' ' ' ASN . 4.5 p -162.93 -157.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 112.335 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.963 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -152.2 164.46 37.3 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.845 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.696 ' HB1' HG13 ' A' ' 90' ' ' ILE . . . -139.96 -175.35 4.2 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.545 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 6.9 mt-30 -136.07 122.35 20.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.683 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.588 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -41.66 116.06 0.73 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.39 0.614 . . . . 0.0 110.37 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.84 -1.76 11.99 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.919 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' PHE . 1.1 mt-30 -126.56 159.79 32.49 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.999 0.4 . . . . 0.0 110.213 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 90.5 p -102.59 -165.41 1.18 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.35 -24.96 46.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.422 0.629 . . . . 0.0 110.209 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -63.24 -41.4 99.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.168 -178.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -75.1 -43.03 55.22 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.334 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.721 ' HB ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -51.19 -61.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 C-N-CA 118.679 -1.208 . . . . 0.0 107.927 177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . . . -30.0 -73.19 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.36 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -48.18 -27.37 2.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.199 -178.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -83.28 -31.55 26.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 179.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.074 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.05 4.94 43.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 10.18 85.78 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.315 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.878 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.3 t -63.58 160.34 44.39 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.384 0.673 . . . . 0.0 111.002 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.878 ' HD2' HG12 ' A' ' 32' ' ' VAL . 9.8 Cg_exo -75.69 4.58 4.97 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.503 2.802 . . . . 0.0 112.306 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 36' ' ' VAL . . . 34.68 30.74 0.01 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.711 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 36' ' ' VAL . 2.8 mp 32.57 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.568 0.223 . . . . 0.0 111.437 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 35' ' ' ILE . 23.8 m -162.92 162.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.76 125.59 4.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.387 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.81 -30.7 14.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.773 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -103.14 -33.22 9.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.98 50.78 62.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.672 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.22 5.27 76.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -83.35 -8.81 59.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 79.1 m 60.74 59.11 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 39' ' ' CYS . 2.8 m -154.07 16.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.829 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -139.91 -170.64 2.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.605 0.24 . . . . 0.0 110.767 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -154.56 19.65 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.649 0.261 . . . . 0.0 111.593 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.648 ' HB ' HG23 ' A' ' 36' ' ' VAL . 1.7 p -82.8 -2.56 54.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.002 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 25.0 p -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.805 ' O ' HD13 ' A' ' 50' ' ' ILE . 18.7 ttt180 -78.02 120.29 22.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 49' ' ' ARG . 7.2 mm -145.9 171.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.062 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' H ' HG22 ' A' ' 50' ' ' ILE . 25.8 mt-10 -139.16 125.85 20.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' CG2' ' HB2' ' A' ' 56' ' ' TRP . 7.7 mm -68.83 147.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.268 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.659 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.76 163.13 1.02 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 117.652 -1.619 . . . . 0.0 107.832 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -79.25 20.64 0.51 Allowed 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.46 -25.95 8.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.109 ' NE1' HD13 ' A' ' 98' ' ' ILE . 27.3 m95 -108.91 2.05 21.19 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.569 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 41.6 t -64.81 -37.85 81.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.003 -1.079 . . . . 0.0 108.872 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -79.54 -5.03 54.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.814 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 93' ' ' SER . 5.7 mt -102.02 -40.39 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.316 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG22 ' HG2' ' A' ' 94' ' ' MET . 20.0 t -92.27 -85.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.551 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 60' ' ' VAL . . . 17.8 62.36 0.01 OUTLIER Glycine 0 C--N 1.342 0.872 0 O-C-N 123.398 0.436 . . . . 0.0 113.257 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.32 -20.21 24.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.745 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . . . -49.94 141.64 10.3 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.422 0.63 . . . . 0.0 111.995 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.632 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 5.9 p-10 -90.82 -172.12 0.31 Allowed Pre-proline 0 N--CA 1.434 -1.268 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.2 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.632 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 14.8 Cg_exo -66.15 2.19 1.97 Allowed 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.331 2.687 . . . . 0.0 113.05 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' HB2' ' OD1' ' A' ' 64' ' ' ASN . 2.2 m-20 -92.44 -51.65 5.04 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.887 0.375 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.662 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -57.65 -34.67 69.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.773 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 1.8 t-20 -70.63 -37.29 73.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.467 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.23 -35.41 61.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -47.96 82.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 74' ' ' THR . 3.2 mm? -70.21 -30.9 68.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.01 -29.32 69.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 p -84.52 13.93 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.478 HG21 HD13 ' A' ' 71' ' ' LEU . 43.4 p -89.27 -23.23 22.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 23.83 44.4 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.463 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -135.26 144.06 48.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.93 137.22 48.06 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.664 2.243 . . . . 0.0 112.282 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.99 -176.84 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.416 ' HG1' ' CD ' ' A' ' 51' ' ' GLU . 1.1 p -139.07 175.41 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.18 106.16 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.988 0.423 . . . . 0.0 111.108 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 113.22 19.14 6.85 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.72 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 108.9 17.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 0.0 110.96 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -138.73 132.75 31.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.677 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 3.7 mt -41.6 154.27 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.575 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.536 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -89.46 -29.21 19.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.602 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 11.7 p -105.59 23.39 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.309 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.581 ' HB3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -128.7 -18.87 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.883 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' SER . 8.9 t -97.03 107.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.5 m-30 -105.57 139.57 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.77 0.795 . . . . 0.0 112.508 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.699 ' CG2' ' HG2' ' A' ' 1' ' ' PRO . 2.6 mm -54.13 144.01 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.154 -1.385 . . . . 0.0 113.331 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 93' ' ' SER . 7.4 p30 -156.17 144.76 14.65 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 27.5 Cg_exo -36.75 -25.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.329 -0.496 0 C-N-CA 121.988 1.792 . . . . 0.0 110.974 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -69.03 -19.18 64.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.876 -1.057 . . . . 0.0 113.694 178.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.641 ' HG2' HG22 ' A' ' 60' ' ' VAL . 1.7 mtp -133.75 50.03 2.24 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.24 0.543 . . . . 0.0 110.212 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.7 ' HA ' ' HB3' ' A' ' 1' ' ' PRO . 1.9 m-20 -91.68 132.05 36.64 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 74.49 31.77 58.49 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -176.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.873 ' HG ' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -72.89 141.51 47.91 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.885 -0.657 . . . . 0.0 111.849 -177.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.109 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -108.16 124.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 -178.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -113.72 166.85 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.319 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -162.95 157.82 21.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.57 0.544 . . . . 0.0 110.669 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 6' ' ' ILE . 92.1 t -102.05 140.26 21.02 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-O 120.756 0.312 . . . . 0.0 111.063 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_endo -55.16 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.669 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -102.96 127.82 29.09 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.357 -179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' LEU . 86.2 Cg_endo -91.58 118.28 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.395 2.73 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.132 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 95' ' ' ASP . 52.2 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 121.77 0.654 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -118.03 161.41 19.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.708 -1.587 . . . . 0.0 107.744 177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.999 HG12 HG12 ' A' ' 15' ' ' VAL . 1.3 t -158.74 166.86 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 C-N-CA 118.137 -1.425 . . . . 0.0 112.634 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 99' ' ' VAL . 13.4 t -152.17 111.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.036 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.811 ' HE2' ' HB2' ' A' ' 27' ' ' ALA . 2.9 m-30 -93.82 176.51 6.32 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.188 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.823 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.5 mm -149.72 163.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.533 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 6.2 t0 -170.95 175.08 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 111.265 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' HB2' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -88.77 -3.36 58.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.065 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -89.38 -37.52 14.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.757 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -131.89 -1.91 3.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.518 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 7' ' ' ASP . . . 60.99 18.69 55.2 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.182 -1.009 . . . . 0.0 112.355 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.546 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 21.4 tt0 169.52 143.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 110.991 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.769 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 41.0 m-85 -146.85 61.99 1.19 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.987 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . . . -50.49 143.35 9.24 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.373 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.123 HG21 ' OD1' ' A' ' 30' ' ' ASN . 5.1 p -166.17 -154.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.941 0.877 . . . . 0.0 112.077 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.961 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -159.76 163.29 34.74 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.107 -179.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.669 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . . . -143.08 -173.58 3.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.974 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' ASP . 5.7 mt-30 -139.7 130.56 26.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.372 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -35.04 109.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.249 0.547 . . . . 0.0 110.824 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 89' ' ' PHE . . . 120.77 -0.32 12.09 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.351 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' OE1' ' CD ' ' A' ' 18' ' ' GLN . 12.1 mt-30 -113.24 141.73 46.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.997 0.398 . . . . 0.0 110.842 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -89.65 -175.83 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.076 HD11 HD21 ' A' ' 97' ' ' LEU . 2.3 mm? -93.83 18.6 10.09 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.664 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.489 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -109.87 -26.13 9.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.216 178.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -90.83 -40.5 11.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.02 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.672 HG12 ' OD1' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -49.67 -56.53 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.366 178.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.811 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . . . -27.61 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.473 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.48 -29.67 2.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 26' ' ' VAL . 2.9 mt-30 -80.72 -29.92 36.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.215 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.123 ' OD1' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -88.6 5.52 42.51 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.65 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.99 -4.89 78.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.057 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.904 HG12 ' HD2' ' A' ' 33' ' ' PRO . 3.8 t -49.44 161.08 0.51 Allowed Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 123.267 0.627 . . . . 0.0 110.507 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.904 ' HD2' HG12 ' A' ' 32' ' ' VAL . 21.6 Cg_exo -70.23 1.94 4.27 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.335 2.69 . . . . 0.0 112.828 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 37.14 56.72 1.41 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.012 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -91.01 46.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.021 0.439 . . . . 0.0 110.353 179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 50' ' ' ILE . 1.3 m -157.86 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.036 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.57 66.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 41.3 tp10 -95.02 -48.63 5.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.0 p -105.49 2.97 28.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 72.54 55.93 6.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 36.56 58.04 1.15 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.2 m -127.44 7.73 6.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.0 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.5 t 60.76 64.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 44' ' ' VAL . 3.2 t -146.85 20.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 38' ' ' GLU . 1.8 p -162.91 -178.42 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB1' HD11 ' A' ' 71' ' ' LEU . . . -138.45 16.15 2.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 38' ' ' GLU . 21.2 p -81.94 -5.72 58.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.915 ' HA ' HG12 ' A' ' 36' ' ' VAL . 5.1 p -89.29 39.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.36 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 102' ' ' PRO . 13.6 tpt180 -52.38 83.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.635 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 36' ' ' VAL . 1.7 mm -97.08 160.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.776 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.627 ' CG ' HG23 ' A' ' 82' ' ' THR . 19.1 mt-10 -138.05 108.75 6.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 HG21 ' A' ' 60' ' ' VAL . 6.6 mm -68.77 143.76 14.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.647 ' HG2' ' HB ' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -55.37 162.3 1.57 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 117.727 -1.589 . . . . 0.0 108.132 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 24.0 t70 -77.92 19.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.637 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -113.06 -25.68 8.83 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.298 0.57 . . . . 0.0 110.096 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.111 ' NE1' HD13 ' A' ' 98' ' ' ILE . 26.9 m95 -107.68 4.34 25.67 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.06 -35.99 73.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.347 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -82.53 -3.36 55.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.702 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 56' ' ' TRP . 8.1 mt -103.84 -36.05 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.853 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 56' ' ' TRP . 40.8 t -86.13 -37.71 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 114.139 -1.392 . . . . 0.0 110.205 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.39 84.21 0.75 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.058 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 63' ' ' ALA . 2.8 mt-10 -47.13 143.33 3.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.429 0.633 . . . . 0.0 109.831 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.668 ' HB3' ' OE2' ' A' ' 67' ' ' GLU . . . -48.99 -170.4 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.16 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.61 ' HB2' ' CD ' ' A' ' 65' ' ' PRO . 4.8 p30 -86.93 174.14 5.8 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.384 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.61 ' CD ' ' HB2' ' A' ' 64' ' ' ASN . 3.4 Cg_exo -75.53 9.0 2.36 Favored 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 124.082 3.188 . . . . 0.0 112.013 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.4 -53.04 4.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 110.324 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' OE2' ' HB3' ' A' ' 63' ' ' ALA . 1.9 pp20? -67.96 -20.56 65.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.386 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.502 ' ND2' ' SD ' ' A' ' 78' ' ' MET . 0.8 OUTLIER -86.58 -23.98 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.798 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 1.8 t0 -76.17 -51.99 11.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 67' ' ' GLU . 1.1 pp -57.16 -30.46 64.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.91 HD11 ' HB1' ' A' ' 46' ' ' ALA . 1.9 mt -84.12 -25.24 29.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.953 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -68.26 -44.75 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -24.51 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -66.84 -60.07 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.944 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.31 27.62 1.32 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.434 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 5.9 mm-40 -99.64 139.72 21.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' GLU . 52.0 Cg_exo -54.47 -177.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.502 ' SD ' ' ND2' ' A' ' 68' ' ' ASN . 76.6 mtp -159.08 126.66 4.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 51' ' ' GLU . 3.8 p -111.44 -174.21 2.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.806 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.58 129.44 34.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.03 89.09 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.691 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.627 HG23 ' CG ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -79.87 109.04 13.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.738 0.304 . . . . 0.0 111.185 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.539 ' HG2' HD12 ' A' ' 84' ' ' LEU . 1.5 tmm_? -167.51 156.47 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -54.49 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.785 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 23' ' ' LEU . 37.8 p -65.47 -35.55 81.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.146 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HB2' ' HG2' ' A' ' 24' ' ' MET . 1.2 p -53.92 -26.09 23.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 110.46 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -82.21 -7.44 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.79 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 60' ' ' VAL . 55.1 t -110.29 162.03 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.267 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 88' ' ' VAL . 46.7 m-85 -150.91 142.61 23.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.017 0.913 . . . . 0.0 113.206 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.669 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 1.7 mm -47.17 161.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 113.874 -1.512 . . . . 0.0 112.712 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 93' ' ' SER . 0.0 OUTLIER 175.78 170.41 0.34 Allowed Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -179.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 24.8 Cg_exo -65.01 45.47 0.15 Allowed 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.296 1.998 . . . . 0.0 111.136 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -142.07 -38.34 0.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.79 -179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.733 ' HG2' HG22 ' A' ' 60' ' ' VAL . 51.4 mtp -111.5 43.42 1.51 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -90.12 122.58 33.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.533 -179.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' ' CZ2' ' A' ' 56' ' ' TRP . . . 78.29 28.17 56.34 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.51 154.41 41.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.72 0.772 . . . . 0.0 112.644 -177.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.111 HD13 ' NE1' ' A' ' 56' ' ' TRP . 1.1 mp -118.62 121.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.283 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.743 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -106.42 178.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.556 179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.654 ' H ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -162.13 157.95 23.99 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.59 0.556 . . . . 0.0 110.377 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 6' ' ' ILE . 61.7 t -116.07 122.57 32.13 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.722 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.639 ' O ' HD23 ' A' ' 103' ' ' LEU . 60.5 Cg_endo -72.11 -178.06 3.0 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.746 2.297 . . . . 0.0 112.668 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 102' ' ' PRO . 1.6 mt -149.28 175.22 2.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.705 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 103' ' ' LEU . 98.2 Cg_endo -85.97 99.63 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.792 2.328 . . . . 0.0 112.613 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.022 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_